Binding	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
to	O
CD4	B-protein
and	I-protein
CXCR4	I-protein
receptors	I-protein
differentially	O
regulates	O
expression	O
of	O
inflammatory	B-DNA
genes	I-DNA
and	O
activates	O
the	O
MEK	B-protein
/ERK	O
signaling	O
pathway	O
.	O

We	O
have	O
previously	O
shown	O
that	O
binding	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
virions	O
to	O
CD4	B-protein
receptors	I-protein
stimulates	O
association	O
of	O
Lck	B-protein
with	O
Raf-1	B-protein
and	O
results	O
in	O
the	O
activation	O
of	O
Raf-1	B-protein
kinase	O
in	O
a	O
Ras-independent	O
manner	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
demonstrate	O
that	O
HIV-1	B-protein
envelope	I-protein
glycoproteins	I-protein
of	O
both	O
T-cell-tropic	O
and	O
macrophagetropic	O
strains	O
rapidly	O
activate	O
the	O
ERK/mitogen-activated	O
protein	O
(	O
MAP	O
)	O
kinase	O
pathway	O
and	O
the	O
binding	O
of	O
nuclear	B-protein
transcription	I-protein
factors	I-protein
(	O
AP-1	B-protein
,	O
NF-kappaB	B-protein
,	O
and	O
C/EBP	B-protein
)	O
and	O
stimulate	O
expression	O
of	O
cytokine	B-DNA
and	I-DNA
chemokine	I-DNA
genes	I-DNA
.	O

The	O
activation	O
of	O
this	O
signaling	O
pathway	O
requires	O
functional	O
CD4	B-protein
receptors	I-protein
and	O
is	O
independent	O
of	O
binding	O
to	O
CXCR4	B-protein
.	O

Binding	O
of	O
the	O
natural	O
ligand	O
stromal	B-protein
cell-derived	I-protein
factor	I-protein
1	I-protein
(	O
SDF-1	B-protein
)	O
to	O
CXCR4	B-protein
,	O
which	O
inhibits	O
entry	O
of	O
T-cell-tropic	O
HIV-1	O
,	O
activates	O
also	O
the	O
ERK/	O
MAP	B-protein
kinase	I-protein
pathway	O
.	O

However	O
,	O
SDF-1	B-protein
did	O
not	O
affect	O
the	O
CD4-mediated	O
expression	O
of	O
cytokine	B-DNA
and	I-DNA
chemokine	I-DNA
genes	I-DNA
.	O

These	O
results	O
provide	O
firm	O
molecular	O
evidence	O
that	O
binding	O
of	O
HIV-1	B-protein
envelope	I-protein
glycoproteins	I-protein
to	O
CD4	B-protein
receptor	I-protein
initiates	O
a	O
signaling	O
pathway	O
(	O
s	O
)	O
independent	O
of	O
the	O
binding	O
to	O
the	O
chemokine	B-protein
receptor	I-protein
that	O
leads	O
to	O
the	O
aberrant	O
expression	O
of	O
inflammatory	B-DNA
genes	I-DNA
and	O
may	O
contribute	O
significantly	O
to	O
HIV-1	O
replication	O
as	O
well	O
as	O
to	O
deregulation	O
of	O
the	O
immune	O
system	O
.	O

JOURNAL	NULL
OF	NULL
ViroLOGY	NULL
,	NULL
Aug.	NULL
1998	NULL
,	NULL
p.	NULL
6406-6413	NULL
0022-538	NULL
Vol	NULL
.	NULL

72	NULL
,	NULL
No	NULL
.	NULL

8	NULL
Copyright	NULL
Â©	NULL
1998	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

Binding	NULL
of	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Type	NULL
1	NULL
to	NULL
CD4	NULL
and	NULL
CXCR4	NULL
Receptors	NULL
Differentially	NULL
Regulates	NULL
Expression	NULL
of	NULL
Inflammatory	NULL
Genes	NULL
and	NULL
Activates	NULL
the	NULL
MEK/ERK	NULL
Signaling	NULL
Pathway	NULL
WALDEMAR	NULL
POPIK	NULL
,	NULL
'	NULL
JOSEPH	NULL
E.	NULL
HESSELGESSER	NULL
,	NULL
``	NULL
anp	NULL
PAULA	NULL
M.	NULL
PITHA***	NULL
Oncology	NULL
Center	NULL
'	NULL
and	NULL
Department	NULL
of	NULL
Molecular	NULL
and	NULL
Genetics	NULL
,	NULL
``	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Baltimore	NULL
,	NULL
Maryland	NULL
21231	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
Berlex	NULL
Biosciences	NULL
,	NULL
Richmond	NULL
,	NULL
California	NULL
94804	NULL
Received	NULL
27	NULL
January	NULL
1998/Accepted	NULL
24	NULL
April	NULL
1998	NULL
We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
binding	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
virions	NULL
to	NULL
CD4	NULL
receptors	NULL
stimulates	NULL
association	NULL
of	NULL
Lok	NULL
with	NULL
Raf-1	NULL
and	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
Raf-1	NULL
kinase	NULL
in	NULL
a	NULL
Ras-independent	NULL
manner	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
HIV-1	NULL
envelope	NULL
glycoproteins	NULL
of	NULL
both	NULL
T-cell-tropic	NULL
and	NULL
macrophagetropic	NULL
strains	NULL
rapidly	NULL
activate	NULL
the	NULL
ERK/mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase	NULL
pathway	NULL
and	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
transcription	NULL
factors	NULL
(	NULL
AP-1	NULL
,	NULL
NF-B	NULL
,	NULL
and	NULL
C/EBP	NULL
)	NULL
and	NULL
stimulate	NULL
expression	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
this	NULL
signaling	NULL
pathway	NULL
requires	NULL
functional	NULL
CD4	NULL
receptors	NULL
and	NULL
is	NULL
independent	NULL
of	NULL
binding	NULL
to	NULL
CXCR4	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
natural	NULL
ligand	NULL
stromal	NULL
cell-derived	NULL
factor	NULL
1	NULL
(	NULL
SDF-1	NULL
)	NULL
to	NULL
CXCR4	NULL
,	NULL
which	NULL
inhibits	NULL
entry	NULL
of	NULL
T-cell-tropic	NULL
HIV-1	NULL
,	NULL
activates	NULL
also	NULL
the	NULL
ERK/MAP	NULL
kinase	NULL
pathway	NULL
.	NULL

However	NULL
,	NULL
SDF-1	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
CD4-mediated	NULL
expression	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
firm	NULL
molecular	NULL
evidence	NULL
that	NULL
binding	NULL
of	NULL
HIV-1	NULL
envelope	NULL
glycoproteins	NULL
to	NULL
CD4	NULL
receptor	NULL
initiates	NULL
a	NULL
signaling	NULL
path-way	NULL
(	NULL
s	NULL
)	NULL
independent	NULL
of	NULL
the	NULL
binding	NULL
to	NULL
the	NULL
chemokine	NULL
receptor	NULL
that	NULL
leads	NULL
to	NULL
the	NULL
aberrant	NULL
expression	NULL
of	NULL
inflammatory	NULL
genes	NULL
and	NULL
may	NULL
contribute	NULL
significantly	NULL
to	NULL
HIV-1	NULL
replication	NULL
as	NULL
well	NULL
as	NULL
to	NULL
deregulation	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Chronic	NULL
activation	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
is	NULL
commonly	NULL
observed	NULL
in	NULL
AIDS	NULL
,	NULL
and	NULL
aberrant	NULL
expression	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
observed	NULL
during	NULL
progression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
disease	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
pathogenicity	NULL
of	NULL
AIDS	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Elevated	NULL
levels	NULL
of	NULL
cytokines	NULL
were	NULL
detected	NULL
in	NULL
serum	NULL
(	NULL
7	NULL
,	NULL
27	NULL
,	NULL
35	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
T	NULL
lymphocytes	NULL
infiltrating	NULL
lymph	NULL
nodes	NULL
of	NULL
HIV-infected	NULL
individuals	NULL
(	NULL
22	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
molecular	NULL
mechanism	NULL
by	NULL
which	NULL
HIV-1	NULL
modulates	NULL
the	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
is	NULL
not	NULL
completely	NULL
under-stood	NULL
.	NULL

The	NULL
HIV-1-mediated	NULL
changes	NULL
in	NULL
cellular	NULL
signaling	NULL
may	NULL
occur	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
HIV-1	NULL
binding	NULL
to	NULL
its	NULL
receptors	NULL
as	NULL
well	NULL
as	NULL
of	NULL
viral	NULL
replication	NULL
.	NULL

The	NULL
Nef	NULL
protein	NULL
,	NULL
encoded	NULL
by	NULL
an	NULL
early	NULL
viral	NULL
gene	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
several	NULL
cellular	NULL
proteins	NULL
such	NULL
as	NULL
tyrosine	NULL
kinases	NULL
Heck	NULL
(	NULL
36	NULL
)	NULL
and	NULL
Lok	NULL
(	NULL
17	NULL
,	NULL
30	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
cellular	NULL
serine/threonine	NULL
kinases	NULL
(	NULL
38	NULL
,	NULL
40	NULL
)	NULL
,	NULL
and	NULL
to	NULL
induce	NULL
synthesis	NULL
of	NULL
interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
in	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
another	NULL
HIV-1	NULL
regulatory	NULL
protein	NULL
,	NULL
Tat	NULL
,	NULL
induced	NULL
both	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
(	NULL
10	NULL
)	NULL
and	NULL
gamma	NULL
interferon	NULL
(	NULL
IFN-y	NULL
)	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
observation	NULL
that	NULL
upregulation	NULL
of	NULL
chemokine	NULL
gene	NULL
production	NULL
in	NULL
PBMC	NULL
requires	NULL
productive	NULL
infection	NULL
implies	NULL
involvement	NULL
of	NULL
HIV-1-encoded	NULL
proteins	NULL
(	NULL
52	NULL
)	NULL
.	NULL

However	NULL
,	NULL
binding	NULL
of	NULL
HIV-1	NULL
virions	NULL
to	NULL
their	NULL
receptors	NULL
alone	NULL
can	NULL
also	NULL
induce	NULL
cellular	NULL
signaling	NULL
since	NULL
both	NULL
the	NULL
primary	NULL
CD4	NULL
receptor	NULL
and	NULL
the	NULL
chemokine	NULL
coreceptors	NULL
(	NULL
19	NULL
,	NULL
59	NULL
)	NULL
can	NULL
trigger	NULL
the	NULL
signaling	NULL
pathway	NULL
upon	NULL
ligand	NULL
binding	NULL
.	NULL

The	NULL
signaling	NULL
potential	NULL
of	NULL
CD4	NULL
is	NULL
mediated	NULL
by	NULL
its	NULL
association	NULL
with	NULL
a	NULL
cytoplasmic	NULL
Src-like	NULL
tyrosine	NULL
kinase	NULL
p56	NULL
``	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Although	NULL
CD4	NULL
generally	NULL
functions	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
Oncology	NULL
Center	NULL
,	NULL
418	NULL
N.	NULL
Bond	NULL
St.	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
21231-1001	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
410	NULL
)	NULL
955-8871	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
410	NULL
)	NULL
955-0840	NULL
.	NULL

E-mail	NULL
:	NULL
parowe	NULL
@	NULL
welchlink	NULL
welch	NULL
jhu.edu	NULL
.	NULL

6406	NULL
by	NULL
association	NULL
with	NULL
the	NULL
T-cell	NULL
receptor	NULL
,	NULL
it	NULL
has	NULL
been	NULL
also	NULL
identified	NULL
as	NULL
a	NULL
receptor	NULL
for	NULL
IL-16	NULL
(	NULL
12	NULL
,	NULL
18	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
can	NULL
transmit	NULL
signals	NULL
independently	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
.	NULL

Binding	NULL
of	NULL
HIV-1	NULL
to	NULL
CD4	NULL
is	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
for	NULL
productive	NULL
infection	NULL
,	NULL
and	NULL
chemokine	NULL
receptors	NULL
CCRS	NULL
and	NULL
CXCR4	NULL
were	NULL
first	NULL
identified	NULL
as	NULL
HIV-1	NULL
coreceptors	NULL
.	NULL

These	NULL
receptors	NULL
belong	NULL
to	NULL
the	NULL
superfamily	NULL
of	NULL
seven-transmembrane	NULL
G-protein-coupled	NULL
receptors	NULL
.	NULL

Binding	NULL
of	NULL
HIV-1	NULL
to	NULL
either	NULL
CXCR4	NULL
or	NULL
CCRS	NULL
receptors	NULL
generally	NULL
determines	NULL
the	NULL
tropism	NULL
of	NULL
HIV-1	NULL
strains	NULL
either	NULL
for	NULL
T	NULL
cells	NULL
or	NULL
macrophages	NULL
,	NULL
respec-tively	NULL
.	NULL

The	NULL
CC	NULL
chemokines	NULL
RANTES	NULL
,	NULL
MIP-1	NULL
Â«	NULL
,	NULL
and	NULL
MIP-18	NULL
were	NULL
found	NULL
to	NULL
suppress	NULL
the	NULL
macrophagetropic	NULL
HIV-1	NULL
infection	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
this	NULL
effect	NULL
is	NULL
related	NULL
to	NULL
both	NULL
the	NULL
ligand	NULL
occupancy	NULL
and	NULL
downregulation	NULL
of	NULL
receptors	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

As	NULL
a	NULL
part	NULL
of	NULL
the	NULL
studies	NULL
of	NULL
the	NULL
role	NULL
of	NULL
cytokines	NULL
in	NULL
HIV-1	NULL
pathogenesis	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
very	NULL
early	NULL
events	NULL
in	NULL
HIV-1	NULL
replication	NULL
and	NULL
showed	NULL
that	NULL
cross-linking	NULL
of	NULL
the	NULL
CD4	NULL
recep-tors	NULL
,	NULL
induced	NULL
by	NULL
binding	NULL
of	NULL
HIV-1	NULL
virions	NULL
to	NULL
T	NULL
cells	NULL
,	NULL
enhanced	NULL
association	NULL
of	NULL
Lek	NULL
with	NULL
Raf-1	NULL
and	NULL
consequently	NULL
activated	NULL
the	NULL
Raf-1	NULL
kinase	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
HIV-1-mediated	NULL
signaling	NULL
did	NULL
not	NULL
result	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
Ras	NULL
GTP-binding	NULL
activity	NULL
or	NULL
its	NULL
association	NULL
with	NULL
Raf-1	NULL
.	NULL

Since	NULL
the	NULL
signaling	NULL
pathway	NULL
generated	NULL
by	NULL
HIV-1	NULL
binding	NULL
is	NULL
not	NULL
identical	NULL
to	NULL
the	NULL
classical	NULL
Ras/	NULL
Raf-1	NULL
pathway	NULL
,	NULL
in	NULL
the	NULL
present	NULL
study	NULL
we	NULL
examined	NULL
(	NULL
i	NULL
)	NULL
whether	NULL
this	NULL
pathway	NULL
is	NULL
functional	NULL
and	NULL
results	NULL
in	NULL
the	NULL
stimulation	NULL
of	NULL
transcriptional	NULL
nuclear	NULL
factors	NULL
and	NULL
activation	NULL
of	NULL
cytokine	NULL
genes	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
whether	NULL
the	NULL
binding	NULL
of	NULL
HIV-1	NULL
virions	NULL
to	NULL
the	NULL
chemokine	NULL
coreceptors	NULL
contributes	NULL
to	NULL
CD4-mediated	NULL
signaling	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
binding	NULL
of	NULL
HIV-1	NULL
to	NULL
CD4	NULL
receptors	NULL
activates	NULL
the	NULL
MEK/ERK	NULL
kinase	NULL
pathway	NULL
,	NULL
stimulates	NULL
the	NULL
expression	NULL
of	NULL
nuclear	NULL
factors	NULL
(	NULL
AP-1	NULL
,	NULL
NF-kB	NULL
,	NULL
and	NULL
C/EBP	NULL
)	NULL
,	NULL
and	NULL
results	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
inflammatory	NULL
genes	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
this	NULL
signaling	NULL
pathway	NULL
is	NULL
independent	NULL
of	NULL
HIV-1	NULL
binding	NULL
to	NULL
the	NULL
chemokine	NULL
receptors	NULL
and	NULL
that	NULL
it	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
CD4-positive	NULL
voL	NULL
.	NULL

72	NULL
,	NULL
1998	NULL
cells	NULL
by	NULL
both	NULL
T-cell-tropic	NULL
and	NULL
macrophagetropic	NULL
HIV-1	NULL
vari-ants	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
.	NULL

Human	NULL
stromal	NULL
cell-derived	NULL
factor	NULL
1a	NULL
(	NULL
SDF-1	NULL
Â«	NULL
)	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Mouse	NULL
monoclonal	NULL
anti-human	NULL
CD4	NULL
(	NULL
Q4120	NULL
)	NULL
,	NULL
control	NULL
mouse	NULL
immunoglobulin	NULL
G1	NULL
,	NULL
and	NULL
goat	NULL
anti-mouse	NULL
antibodies	NULL
were	NULL
from	NULL
Sigma	NULL
.	NULL

Recombinant	NULL
gp120	NULL
envelope	NULL
glycoprotein	NULL
from	NULL
the	NULL
T-cell-tropic	NULL
HIV-1	NULL
IIIB	NULL
(	NULL
gp120	NULL
IIIB	NULL
)	NULL
and	NULL
mouse	NULL
anti-gp120	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
Intracel	NULL
(	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

Phosphoprotein-specific	NULL
antibodies	NULL
detecting	NULL
MEK1/2	NULL
when	NULL
activated	NULL
by	NULL
phosphorylation	NULL
at	NULL
Ser217/221	NULL
and	NULL
ERK1/2	NULL
(	NULL
p44/p42	NULL
mitogen-activated	NULL
protein	NULL
[	NULL
MAP	NULL
]	NULL
kinase	NULL
)	NULL
when	NULL
activated	NULL
by	NULL
phosphorylation	NULL
at	NULL
Thr202	NULL
and	NULL
Tyr204	NULL
as	NULL
well	NULL
as	NULL
antibodies	NULL
detecting	NULL
total	NULL
levels	NULL
of	NULL
MEK1/2	NULL
and	NULL
ERK1/2	NULL
were	NULL
purchased	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
(	NULL
Beverly	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

Cell	NULL
cultures	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
,	NULL
clone	NULL
E6-1	NULL
(	NULL
ATCC	NULL
TIB-152	NULL
)	NULL
,	NULL
and	NULL
A2.01/CD4.401	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
Sigma	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
r-glutamine	NULL
,	NULL
and	NULL
gentamicin	NULL
(	NULL
50	NULL
pg/ml	NULL
)	NULL
.	NULL

Before	NULL
using	NULL
in	NULL
experiments	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
starved	NULL
for	NULL
24	NULL
h	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
0.5	NULL
%	NULL
FCS	NULL
.	NULL

Virus	NULL
stock	NULL
preparation	NULL
and	NULL
virus	NULL
titer	NULL
.	NULL

Viral	NULL
stock	NULL
of	NULL
the	NULL
NL4-3	NULL
clone	NULL
of	NULL
HIV-1	NULL
was	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Viral	NULL
stock	NULL
of	NULL
macrophagetropic	NULL
clone	NULL
ADS	NULL
(	NULL
57	NULL
)	NULL
,	NULL
obtained	NULL
from	NULL
F.	NULL
Maldarelli	NULL
(	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
)	NULL
,	NULL
was	NULL
produced	NULL
by	NULL
electroporation	NULL
of	NULL
the	NULL
molecular	NULL
clone	NULL
into	NULL
Jurkat	NULL
cells	NULL
and	NULL
expansion	NULL
in	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
-stimulated	NULL
PBMC	NULL
.	NULL

HIV-1	NULL
Ba-L	NULL
(	NULL
28	NULL
)	NULL
stock	NULL
was	NULL
generated	NULL
by	NULL
infecting	NULL
PHA-stimulated	NULL
PBMC	NULL
with	NULL
cell-free	NULL
virus	NULL
(	NULL
obtained	NULL
from	NULL
S.	NULL
Gartner	NULL
,	NULL
Johns	NULL
Hopkins	NULL
University	NULL
,	NULL
Baltimore	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

.	NULL

Viral	NULL
stocks	NULL
of	NULL
the	NULL
replication-competent	NULL
NL4-3-derived	NULL
envelope	NULL
mutants	NULL
with	NULL
significantly	NULL
reduced	NULL
binding	NULL
to	NULL
CD4	NULL
,	NULL
NL-D368E	NULL
and	NULL
NL-D368P	NULL
(	NULL
obtained	NULL
from	NULL
D.	NULL
Kabat	NULL
,	NULL
Oregon	NULL
Health	NULL
Sciences	NULL
University	NULL
,	NULL
Portland	NULL
)	NULL
,	NULL
were	NULL
produced	NULL
by	NULL
transfection	NULL
of	NULL
293T	NULL
cells	NULL
with	NULL
plasmid	NULL
DNA	NULL
and	NULL
collecting	NULL
culture	NULL
supernatants	NULL
48	NULL
h	NULL
later	NULL
.	NULL

All	NULL
culture	NULL
supernatants	NULL
containing	NULL
HIV-1	NULL
were	NULL
clarified	NULL
by	NULL
low-speed	NULL
centrifugation	NULL
and	NULL
filtration	NULL
through	NULL
a	NULL
0.45-pm-pore-size	NULL
filter	NULL
and	NULL
kept	NULL
frozen	NULL
at	NULL
-80Â°C	NULL
,	NULL
or	NULL
virus	NULL
was	NULL
concentrated	NULL
and	NULL
purified	NULL
by	NULL
ultracentrifugation	NULL
through	NULL
a	NULL
cushion	NULL
of	NULL
sucrose	NULL
buffer	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Pelleted	NULL
virus	NULL
was	NULL
used	NULL
immediately	NULL
in	NULL
experiments	NULL
after	NULL
resuspension	NULL
in	NULL
RPMI-0.5	NULL
%	NULL
FCS	NULL
.	NULL

The	NULL
virus	NULL
titer	NULL
was	NULL
monitored	NULL
by	NULL
the	NULL
reverse	NULL
transcriptase	NULL
(	NULL
RT	NULL
)	NULL
activity	NULL
assay	NULL
(	NULL
55	NULL
)	NULL
and	NULL
the	NULL
infectivity	NULL
titer	NULL
(	NULL
47	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
gp120	NULL
envelope	NULL
in	NULL
various	NULL
viral	NULL
preparations	NULL
were	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

In	NULL
the	NULL
induction	NULL
proto-col	NULL
,	NULL
the	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10	NULL
``	NULL
to	NULL
2	NULL
x	NULL
10	NULL
``	NULL
cells/ml	NULL
in	NULL
RPMI-0.5	NULL
%	NULL
FCS	NULL
)	NULL
were	NULL
preincubated	NULL
on	NULL
ice	NULL
for	NULL
60	NULL
min	NULL
with	NULL
the	NULL
purified	NULL
virus	NULL
(	NULL
5	NULL
RT	NULL
units/cell	NULL
)	NULL
and	NULL
then	NULL
transferred	NULL
immediately	NULL
to	NULL
37Â°C	NULL
and	NULL
incubated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
followed	NULL
by	NULL
washing	NULL
twice	NULL
in	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
lysis	NULL
in	NULL
protein	NULL
or	NULL
RNA	NULL
lysis	NULL
buffer	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
.	NULL

Cell	NULL
aliquots	NULL
(	NULL
10	NULL
'	NULL
cells	NULL
)	NULL
were	NULL
solubilized	NULL
in	NULL
ice-cold	NULL
lysis	NULL
buffer	NULL
containing	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
50	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
100	NULL
mM	NULL
NaC	NULL
)	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
supplemented	NULL
with	NULL
the	NULL
protease	NULL
inhibitors	NULL
leupeptin	NULL
(	NULL
10	NULL
pg/ml	NULL
!	NULL
)	NULL

and	NULL
aprotinin	NULL
(	NULL
10	NULL
pg/ml	NULL
!	NULL
)	NULL

and	NULL
the	NULL
phosphatase	NULL
inhibitors	NULL
sodium	NULL
orthovanadate	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
,	NULL
sodium	NULL
fluoride	NULL
(	NULL
50	NULL
mM	NULL
)	NULL
,	NULL
and	NULL
B-glyc-erophosphate	NULL
(	NULL
20	NULL
mM	NULL
)	NULL
.	NULL

After	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
lysates	NULL
were	NULL
clarified	NULL
by	NULL
ultra-centrifugation	NULL
.	NULL

Protein	NULL
concentrations	NULL
of	NULL
the	NULL
lysates	NULL
were	NULL
determined	NULL
with	NULL
the	NULL
Pierce	NULL
(	NULL
Rockford	NULL
,	NULL
II	NULL
.	NULL
)	NULL

bicinchoninic	NULL
acid	NULL
protein	NULL
assay	NULL
reagent	NULL
.	NULL

Proteins	NULL
(	NULL
50	NULL
pug	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
(	NULL
10	NULL
%	NULL
acrylamide	NULL
gel	NULL
)	NULL
,	NULL
transferred	NULL
to	NULL
supported	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
probed	NULL
with	NULL
specific	NULL
antibodies	NULL
(	NULL
usually	NULL
diluted	NULL
1:1,000	NULL
)	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
secondary	NULL
-	NULL
horseradish	NULL
-	NULL
peroxidase-conjugated	NULL
-	NULL
antibody	NULL
(	NULL
1:100,000	NULL
)	NULL
.	NULL

Bound	NULL
antibodies	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
SuperSignal	NULL
ULTRA	NULL
chemiluminescent	NULL
substrate	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
mRNA	NULL
expression	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
using	NULL
RNeasy	NULL
Total	NULL
RNA	NULL
purification	NULL
system	NULL
(	NULL
Qiagen	NULL
)	NULL
,	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
DNase-treated	NULL
RNA	NULL
was	NULL
used	NULL
for	NULL
cDNA	NULL
synthesis	NULL
using	NULL
Superscript	NULL
II	NULL
RNase	NULL
H	NULL
RT	NULL
and	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
;	NULL
,	NULL
,	NULL
,	NULL
primers	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
;	NULL
1/10	NULL
of	NULL
this	NULL
reaction	NULL
product	NULL
was	NULL
used	NULL
as	NULL
a	NULL
template	NULL
for	NULL
PCR	NULL
amplification	NULL
with	NULL
Taq	NULL
polymerase	NULL
(	NULL
Supermix	NULL
;	NULL
Gibco-BRL	NULL
)	NULL
.	NULL

The	NULL
mRNA	NULL
for	NULL
glyceraldehyde	NULL
3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
or	NULL
Raf-1	NULL
kinase	NULL
served	NULL
as	NULL
internal	NULL
control	NULL
.	NULL

Primers	NULL
for	NULL
CXCR4	NULL
,	NULL
GAPDH	NULL
(	NULL
39	NULL
)	NULL
,	NULL
CCRS5	NULL
(	NULL
20	NULL
)	NULL
,	NULL
MIP-1a	NULL
,	NULL
MIP-18	NULL
,	NULL
and	NULL
TNF-a	NULL
(	NULL
60	NULL
)	NULL
as	NULL
well	NULL
as	NULL
amplification	NULL
conditions	NULL
were	NULL
described	NULL
elsewhere	NULL
.	NULL

Primers	NULL
for	NULL
IL-2	NULL
were	NULL
from	NULL
Strat-agene	NULL
.	NULL

The	NULL
following	NULL
primers	NULL
were	NULL
used	NULL
:	NULL
for	NULL
IFN-y	NULL
(	NULL
413	NULL
bp	NULL
)	NULL
,	NULL
5'-CTGTTACTG	NULL
CCAGGACCCAT-3	NULL
'	NULL
-	NULL
(	NULL
sense	NULL
)	NULL
-	NULL
and	NULL
-	NULL
5'-GCATCTGACTCCTTTITCGC-3	NULL
(	NULL
antisense	NULL
)	NULL
;	NULL
for	NULL
IL-6	NULL
(	NULL
347	NULL
bp	NULL
)	NULL
,	NULL
5'-GAACTCCITCTCCACAAGCG-3	NULL
'	NULL
(	NULL
sense	NULL
)	NULL
and	NULL
5'-TGATGATITTCACCAGGCAA-3	NULL
'	NULL
(	NULL
antisense	NULL
)	NULL
;	NULL
for	NULL
Fas	NULL
antigen	NULL
(	NULL
357	NULL
bp	NULL
)	NULL
,	NULL
5'-ATAAGCCCTGTCCTCCAGGT-3	NULL
'	NULL
(	NULL
sense	NULL
)	NULL
and	NULL
5'-GACAAAGCCAC	NULL
CCCAAGTTA-3	NULL
'	NULL
(	NULL
antisense	NULL
)	NULL
;	NULL
and	NULL
for	NULL
Fas	NULL
ligand	NULL
(	NULL
439	NULL
bp	NULL
)	NULL
,	NULL
5	NULL
``	NULL
-CACCTACAGA	NULL
AGGAGCTGGC-3	NULL
'	NULL
(	NULL
sense	NULL
)	NULL
and	NULL
5	NULL
``	NULL
-TAAGATTGAACACTGCCCCC-3	NULL
'	NULL
(	NULL
anti-sense	NULL
)	NULL
.	NULL

These	NULL
cDNAs	NULL
were	NULL
amplified	NULL
for	NULL
30	NULL
cycles	NULL
(	NULL
94Â°C	NULL
for	NULL
45	NULL
s	NULL
,	NULL
60Â°C	NULL
for	NULL
45	NULL
s	NULL
,	NULL
and	NULL
72Â°C	NULL
for	NULL
1.5	NULL
min	NULL
)	NULL
,	NULL
and	NULL
PCR	NULL
products	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
in	NULL
2	NULL
%	NULL
agarose	NULL
gels	NULL
and	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Nuclear	NULL
extracts	NULL
for	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Double-stranded	NULL
oligonucleotides	NULL
representing	NULL
consensus	NULL
and	NULL
mutated	NULL
binding	NULL
motifs	NULL
for	NULL
transcription	NULL
factors	NULL
NF-	NULL
Â«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
C/EBP	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
were	NULL
end	NULL
labeled	NULL
by	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
and	NULL
[	NULL
y-*Â°P	NULL
]	NULL
JATP	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
HIV-1	NULL
SIGNALING	NULL
IN	NULL
INFLAMMATORY	NULL
GENE	NULL
EXPRESSION	NULL
-	NULL
6407	NULL
2	NULL
.	NULL

2	NULL
a	NULL
a	NULL
f	NULL
[	NULL
>	NULL
>	NULL
>	NULL
,	NULL
A	NULL
.	NULL

8	NULL
=	NULL
|	NULL
a	NULL
gp120	NULL
IIIB	NULL
30	NULL
-	NULL
10x	NULL
50x	NULL
_	NULL
AP-1	NULL
competitor	NULL
<	NULL
-	NULL
AP-1	NULL
Wh	NULL
i	NULL
Â»	NULL
Â®	NULL
-	NULL
<	NULL
-	NULL
NS	NULL
woul	NULL
<	NULL
-	NULL
NSs	NULL
(	NULL
ONN	NULL
s.	NULL
,	NULL
20	NULL
.	NULL

2	NULL
a	NULL
a	NULL
â¬	NULL
A	NULL
a	NULL
<	NULL
-	NULL
120	NULL
IIIB	NULL
2h	NULL
g	NULL
>	NULL
>	NULL
>	NULL
B	NULL
.	NULL

2A	NULL
&	NULL
A	NULL
2	NULL
0	NULL
=	NULL
=	NULL
a	NULL
-	NULL
10x	NULL
50x	NULL
_	NULL
NF-kB	NULL
competitor	NULL
<	NULL
-	NULL
pS0-p65	NULL
-	NULL
>	NULL
<	NULL
-	NULL
p50-p50	NULL
-	NULL
,	NULL
<	NULL
NS	NULL
<	NULL
-	NULL
NS	NULL
#	NULL
020	NULL
.	NULL

#	NULL
0.	NULL
.	NULL

2	NULL
``	NULL
2	NULL
&	NULL
a	NULL
2	NULL
2	NULL
2	NULL
&	NULL
2	NULL
a	NULL
tomo	NULL
u	NULL
Â§	NULL
om	NULL
-o	NULL
I	NULL
a	NULL
>	NULL
>	NULL
_	NULL
>	NULL
c.	NULL
&	NULL
$	NULL
i	NULL
R	NULL
R	NULL
8	NULL
R	NULL
R	NULL
R	NULL
C/EBP	NULL
-	NULL
>	NULL
tnd	NULL
<	NULL
~	NULL
pt	NULL
mut	NULL
.	NULL

C/EBP	NULL
oligo	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Binding	NULL
of	NULL
T-cell-tropic	NULL
NL4-3	NULL
or	NULL
IIIB	NULL
glycoprotein	NULL
gp120	NULL
to	NULL
CD4*	NULL
Jurkat	NULL
T	NULL
cells	NULL
induces	NULL
nuclear	NULL
accumulation	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
unstimulated	NULL
(	NULL
control	NULL
)	NULL
cells	NULL
or	NULL
cells	NULL
exposed	NULL
to	NULL
NL4-3	NULL
(	NULL
HIV-1	NULL
)	NULL
or	NULL
gp120	NULL
IIIB	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Radiola-beled	NULL
double-stranded	NULL
oligonucleotides	NULL
representing	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
AP-1	NULL
(	NULL
A	NULL
)	NULL
,	NULL
NF-	NULL
Â«	NULL
B	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
C/EBP	NULL
(	NULL
C	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
(	NULL
6	NULL
pg	NULL
)	NULL
,	NULL
and	NULL
formed	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Specificity	NULL
of	NULL
induction	NULL
of	NULL
AP-1	NULL
and	NULL
NF-	NULL
Â«	NULL
B	NULL
was	NULL
determined	NULL
by	NULL
competition	NULL
with	NULL
10-	NULL
and	NULL
50-fold	NULL
molar	NULL
excesses	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
representing	NULL
appropriate	NULL
consensus	NULL
binding	NULL
sites	NULL
.	NULL

Protein	NULL
composition	NULL
of	NULL
the	NULL
NF-	NULL
Â«	NULL
B	NULL
complexes	NULL
was	NULL
determined	NULL
in	NULL
a	NULL
supershift	NULL
assay	NULL
using	NULL
specific	NULL
antibodies	NULL
against	NULL
p30	NULL
or	NULL
p63	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
formation	NULL
of	NULL
C/EBP	NULL
was	NULL
determined	NULL
by	NULL
using	NULL
end-labeled	NULL
oligonucleotides	NULL
with	NULL
mutated	NULL
binding	NULL
sites	NULL
(	NULL
mut	NULL
.	NULL

C/EBP	NULL
oligo	NULL
)	NULL
.	NULL

NS	NULL
represents	NULL
nonspecific	NULL
binding	NULL
.	NULL

binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
consensus	NULL
oligonucleotides	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
complex	NULL
formation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10-	NULL
or	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
corresponding	NULL
oligonucleotide	NULL
or	NULL
by	NULL
using	NULL
oligonucleotides	NULL
with	NULL
mutated	NULL
binding	NULL
sites	NULL
.	NULL

Protein	NULL
composition	NULL
of	NULL
the	NULL
formed	NULL
complexes	NULL
was	NULL
identified	NULL
in	NULL
a	NULL
supershift	NULL
assay	NULL
using	NULL
specific	NULL
antibodies	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

RESULTS	NULL
Binding	NULL
of	NULL
HIV-1	NULL
to	NULL
CD4*	NULL
T	NULL
cells	NULL
induces	NULL
rapid	NULL
accumulation	NULL
of	NULL
nuclear	NULL
transcription	NULL
factors	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
binding	NULL
of	NULL
HIV-1	NULL
virions	NULL
to	NULL
CD4	NULL
receptors	NULL
stimulates	NULL
association	NULL
of	NULL
tyrosine	NULL
kinase	NULL
p56	NULL
``	NULL
with	NULL
serine/threonine	NULL
kinase	NULL
Raf-1	NULL
and	NULL
activates	NULL
Raf-1	NULL
in	NULL
a	NULL
Ras-independent	NULL
manner	NULL
(	NULL
47	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
Raf-1-mediated	NULL
signaling	NULL
is	NULL
functional	NULL
,	NULL
we	NULL
examined	NULL
,	NULL
by	NULL
a	NULL
gel	NULL
retardation	NULL
assay	NULL
,	NULL
the	NULL
accumulation	NULL
of	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
T-cell-tropic	NULL
NLA-3	NULL
HIV-1	NULL
.	NULL

The	NULL
results	NULL
show	NULL
a	NULL
rapid	NULL
nuclear	NULL
accumulation	NULL
of	NULL
AP-1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
as	NULL
early	NULL
as	NULL
30	NULL
min	NULL
after	NULL
HIV-1	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
binding	NULL
of	NULL
gp120	NULL
IIIB	NULL
to	NULL
Jurkat	NULL
cells	NULL
also	NULL
resulted	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
AP-1	NULL
was	NULL
specific	NULL
and	NULL
was	NULL
inhibited	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10-	NULL
or	NULL
50-fold	NULL
molar	NULL
6408	NULL
POPIK	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
.	NULL

â¬	NULL
ps	NULL
.	NULL

.E	NULL
anti-CD4	NULL
go	NULL
+	NULL
I	NULL
$	NULL
S	NULL
M	NULL
5	NULL
A	NULL
a	NULL
Â§	NULL
#	NULL
&	NULL
were	NULL
mme	NULL
.	NULL

<	NULL
+	NULL
â¬	NULL
TNF-a	NULL
Â«	NULL
n	NULL
!	NULL

come	NULL
en	NULL
:	NULL
â¬	NULL
IL-6	NULL
j	NULL
u	NULL
'	NULL
$	NULL
camp	NULL
came	NULL
comp	NULL
comp	NULL
come	NULL
cmp	NULL
<	NULL
Rof.|	NULL
J.	NULL
ViRoL	NULL
.	NULL

a	NULL
B	NULL
.	NULL

<	NULL
U	NULL
E	NULL
:	NULL
anti-CD4	NULL
3	NULL
+	NULL
E	NULL
E	NULL
@	NULL
)	NULL
a	NULL
)	NULL
Â£	NULL
!	NULL

%	NULL
M	NULL
5	NULL
&	NULL
m	NULL
6	NULL
a	NULL
a	NULL
M	NULL
wom	NULL
Guu	NULL
came	NULL
â¬	NULL
MIP-10	NULL
600-	NULL
-	NULL
sa	NULL
Â«	NULL
ee	NULL
mas	NULL
â¬	NULL
MIP-18	NULL
600-	NULL
==	NULL
Â»	NULL
*~	NULL
--	NULL
weme	NULL
P	NULL
Â«	NULL
--	NULL
ame	NULL
â¬FASL	NULL
ss	NULL
ume	NULL
ap	NULL
oss	NULL
cams	NULL
comp	NULL
â¬	NULL
FAS	NULL
w	NULL
frcus	NULL
600-	NULL
-	NULL
omy	NULL
cont	NULL
Gone	NULL
cong	NULL
Gung	NULL
<	NULL
GAPDH	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
of	NULL
cytokine	NULL
,	NULL
chemokine	NULL
,	NULL
and	NULL
FasL/Fas	NULL
mRNA	NULL
expression	NULL
stimulated	NULL
by	NULL
anti-CD4	NULL
antibody	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
unstimulated	NULL
(	NULL
unstim	NULL
.	NULL
)	NULL

,	NULL
treated	NULL
for	NULL
16	NULL
h	NULL
with	NULL
PHA	NULL
(	NULL
5	NULL
pg/ml	NULL
!	NULL
)	NULL

and	NULL
TPA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
anti-CD4	NULL
antibody	NULL
Q4120	NULL
(	NULL
10	NULL
g/m	NULL
!	NULL
)	NULL

for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

RT-PCR-assisted	NULL
amplification	NULL
of	NULL
cytokine	NULL
(	NULL
A	NULL
)	NULL
and	NULL
chemokine	NULL
and	NULL
FasL/Fas	NULL
(	NULL
B	NULL
)	NULL
mRNAs	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
in	NULL
2	NULL
%	NULL
agarose	NULL
gels	NULL
and	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

Raf-1	NULL
and	NULL
GAPDH	NULL
represent	NULL
internal	NULL
controls	NULL
.	NULL

M	NULL
,	NULL
100-bp	NULL
molecular	NULL
size	NULL
markers	NULL
(	NULL
600-bp	NULL
band	NULL
marked	NULL
on	NULL
the	NULL
left	NULL
)	NULL
.	NULL

excess	NULL
of	NULL
an	NULL
unlabeled	NULL
oligonucleotide	NULL
representing	NULL
AP-1	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
Jurkat	NULL
T	NULL
cells	NULL
show	NULL
a	NULL
presence	NULL
of	NULL
a	NULL
single	NULL
NF-	NULL
Â«	NULL
B	NULL
complex	NULL
representing	NULL
p50	NULL
homodimers	NULL
(	NULL
as	NULL
determined	NULL
in	NULL
supershift	NULL
assay	NULL
[	NULL
data	NULL
not	NULL
shown	NULL
]	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
p50/p65	NULL
NF-kB	NULL
heterodimers	NULL
was	NULL
detected	NULL
only	NULL
after	NULL
the	NULL
stimulation	NULL
with	NULL
NL4-3	NULL
virions	NULL
or	NULL
gp120	NULL
IIIB	NULL
and	NULL
reached	NULL
a	NULL
maximum	NULL
by	NULL
2	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
was	NULL
specific	NULL
and	NULL
could	NULL
be	NULL
abolished	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10-	NULL
or	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
an	NULL
unlabeled	NULL
NF-xB	NULL
consensus	NULL
oligonucleotide	NULL
.	NULL

Stimulation	NULL
of	NULL
NF-kB	NULL
binding	NULL
was	NULL
also	NULL
abolished	NULL
when	NULL
the	NULL
HIV-1	NULL
virions	NULL
were	NULL
pretreated	NULL
with	NULL
soluble	NULL
CD4	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
treatment	NULL
that	NULL
also	NULL
abolished	NULL
Raf-1	NULL
activation	NULL
(	NULL
47	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
accordance	NULL
with	NULL
results	NULL
reported	NULL
by	NULL
others	NULL
(	NULL
4	NULL
,	NULL
9	NULL
,	NULL
13	NULL
,	NULL
15	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
and	NULL
NF-	NULL
Â«	NULL
B	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
binding	NULL
of	NULL
HIV-1	NULL
virions	NULL
to	NULL
Jurkat	NULL
cells	NULL
resulted	NULL
also	NULL
in	NULL
a	NULL
rapid	NULL
nuclear	NULL
accumulation	NULL
of	NULL
C/EBP	NULL
(	NULL
NF-IL6	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
that	NULL
is	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
promoters	NULL
of	NULL
several	NULL
early-response	NULL
genes	NULL
and	NULL
is	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
activity	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
C/EBP	NULL
was	NULL
specific	NULL
since	NULL
it	NULL
was	NULL
not	NULL
observed	NULL
with	NULL
oligonucleotide	NULL
representing	NULL
mutated	NULL
C/EBP	NULL
binding	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
interaction	NULL
of	NULL
HIV-1	NULL
with	NULL
CD4	NULL
receptor	NULL
results	NULL
in	NULL
the	NULL
stimulation	NULL
of	NULL
Raf-1	NULL
activity	NULL
and	NULL
nuclear	NULL
accumulation	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
inflammatory	NULL
genes	NULL
as	NULL
well	NULL
as	NULL
the	NULL
HIV-1	NULL
promoter	NULL
.	NULL

Anti-CD4	NULL
receptor	NULL
antibodies	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
inflammatory	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
.	NULL

Productive	NULL
viral	NULL
replication	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
proinflam-matory	NULL
cytokines	NULL
in	NULL
infected	NULL
monocytes	NULL
(	NULL
52	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
was	NULL
recently	NULL
shown	NULL
that	NULL
cross-linking	NULL
of	NULL
CD4	NULL
receptors	NULL
on	NULL
unfrac-tionated	NULL
PBMC	NULL
was	NULL
sufficient	NULL
to	NULL
induce	NULL
IFN-y	NULL
and	NULL
TNF-	NULL
Â«	NULL
gene	NULL
expression	NULL
(	NULL
43	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
HIV-1-stimulated	NULL
pathway	NULL
leads	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
,	NULL
we	NULL
first	NULL
analyzed	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
cytokine	NULL
mRNA	NULL
in	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
CD4-positive	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Since	NULL
Raf-1	NULL
activity	NULL
can	NULL
be	NULL
effectively	NULL
induced	NULL
in	NULL
Jurkat	NULL
cells	NULL
by	NULL
cross-linking	NULL
of	NULL
CD4	NULL
receptors	NULL
(	NULL
47	NULL
)	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
monoclonal	NULL
anti-CD4	NULL
antibody	NULL
Q4120	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
inflammatory	NULL
genes	NULL
was	NULL
analyzed	NULL
by	NULL
semiquantitative	NULL
RT-PCR	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

To	NULL
control	NULL
for	NULL
possible	NULL
differences	NULL
in	NULL
RNA	NULL
levels	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
Raf-1	NULL
and	NULL
GAPDH	NULL
RNAs	NULL
as	NULL
internal	NULL
controls	NULL
.	NULL

Stimulation	NULL
with	NULL
the	NULL
anti-CD4	NULL
antibody	NULL
induced	NULL
high	NULL
levels	NULL
of	NULL
TNF-a	NULL
and	NULL
IFN-y	NULL
transcripts	NULL
that	NULL
could	NULL
be	NULL
detected	NULL
for	NULL
up	NULL
to	NULL
9	NULL
h	NULL
after	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

In	NULL
unstimulated	NULL
cells	NULL
exposed	NULL
to	NULL
isotype-matched	NULL
control	NULL
mouse	NULL
antibody	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
cytokine	NULL
genes	NULL
was	NULL
very	NULL
low	NULL
or	NULL
undetectable	NULL
.	NULL

Cells	NULL
stimulated	NULL
with	NULL
PHA	NULL
and	NULL
phorbol	NULL
ester	NULL
(	NULL
tetradecanoyl	NULL
phorbol	NULL
acetate	NULL
[	NULL
TPA	NULL
]	NULL
)	NULL
served	NULL
as	NULL
positive	NULL
controls	NULL
and	NULL
showed	NULL
high	NULL
levels	NULL
of	NULL
TNF-a	NULL
,	NULL
IFN-y	NULL
,	NULL
and	NULL
IL-2	NULL
mRNAs	NULL
.	NULL

Interestingly	NULL
,	NULL
cross-linking	NULL
of	NULL
CD4	NULL
receptors	NULL
also	NULL
induced	NULL
expression	NULL
of	NULL
chemokine	NULL
MIP-18	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
MIP-1a	NULL
Â«	NULL
genes	NULL
that	NULL
were	NULL
not	NULL
expressed	NULL
in	NULL
uninduced	NULL
cells	NULL
but	NULL
were	NULL
induced	NULL
by	NULL
PHA	NULL
and	NULL
TPA	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
CD4-dependent	NULL
pathway	NULL
also	NULL
increased	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
RANTES	NULL
mRNA	NULL
,	NULL
although	NULL
RANTES	NULL
mRNA	NULL
could	NULL
also	NULL
be	NULL
detected	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Promoters	NULL
of	NULL
RANTES	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
IL-6	NULL
genes	NULL
contain	NULL
cis-acting	NULL
elements	NULL
that	NULL
may	NULL
serve	NULL
as	NULL
binding	NULL
sites	NULL
for	NULL
NF-kB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
C/EBP	NULL
that	NULL
are	NULL
induced	NULL
in	NULL
HIV-1-stimulated	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
conceivable	NULL
that	NULL
CD4-mediated	NULL
binding	NULL
of	NULL
HIV-1	NULL
virions	NULL
to	NULL
the	NULL
cells	NULL
alone	NULL
stimulates	NULL
transcription	NULL
of	NULL
these	NULL
inflammatory	NULL
genes	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
have	NULL
detected	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
Fas	NULL
antigen	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
Fas	NULL
ligand	NULL
was	NULL
transient	NULL
and	NULL
was	NULL
significantly	NULL
upregulated	NULL
by	NULL
anti-CD4	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
gp120	NULL
and	NULL
anti-CD4	NULL
antibodies	NULL
activates	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
binding	NULL
of	NULL
gp120	NULL
or	NULL
anti-CD4	NULL
antibodies	NULL
to	NULL
CD4	NULL
receptors	NULL
activates	NULL
MAP	NULL
kinase	NULL
pathway	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
levels	NULL
of	NULL
phosphorylated	NULL
MEK1/2	NULL
(	NULL
a	NULL
direct	NULL
cellular	NULL
substrate	NULL
for	NULL
activated	NULL
Raf-1	NULL
)	NULL
and	NULL
ERK1/2	NULL
kinases	NULL
in	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
for	NULL
different	NULL
times	NULL
with	NULL
recombinant	NULL
gp120	NULL
IIIB	NULL
or	NULL
anti-CD4	NULL
(	NULL
Q4120	NULL
)	NULL
antibodies	NULL
.	NULL

Using	NULL
antibodies	NULL
which	NULL
can	NULL
specifically	NULL
recognize	NULL
the	NULL
activated	NULL
and	NULL
phosphorylated	NULL
forms	NULL
of	NULL
MEK1/2	NULL
and	NULL
ERK1/2	NULL
kinases	NULL
,	NULL
we	NULL
found	NULL
that	NULL
stimulation	NULL
with	NULL
gp120	NULL
or	NULL
anti-CD4	NULL
antibodies	NULL
that	NULL
induced	NULL
cytokine	NULL
and	NULL
chemokine	NULL
gene	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
also	NULL
resulted	NULL
in	NULL
a	NULL
fast	NULL
and	NULL
transient	NULL
phosphorylation	NULL
of	NULL
MEK1/2	NULL
voL	NULL
.	NULL

72	NULL
,	NULL
1998	NULL
3	NULL
a	NULL
:	NULL
ille	NULL
3	NULL
)	NULL
\Â¢	NULL
)	NULL
)	NULL
42	NULL
&	NULL
*	NULL
``	NULL
.	NULL

7	NULL
,	NULL
9	NULL
E=	NULL
I	NULL
|	NULL
&	NULL
2	NULL
8	NULL
)	NULL
8	NULL
)	NULL
&	NULL
)	NULL
a	NULL
)	NULL
a	NULL
)	NULL
8	NULL
y	NULL
\	NULL
&	NULL
3	NULL
)	NULL
z	NULL
2	NULL
7	NULL
)	NULL
%	NULL
v3	NULL
8	NULL
8	NULL
s	NULL
8	NULL
2	NULL
67	NULL
56	NULL
42	NULL
-	NULL
~	NULL
:	NULL
_._	NULL
:	NULL
_ââ	NULL
<	NULL
âMEK-P	NULL
28	NULL
woo	NULL
ame	NULL
Â«	NULL
Â«	NULL
Â»	NULL
Â«	NULL
Â¥	NULL
te	NULL
cme	NULL
<	NULL
-	NULL
MEK	NULL
67	NULL
56	NULL
42	NULL
~	NULL
uz	NULL
P	NULL
A	NULL
<	NULL
-	NULL
ERK1/2-P	NULL
28	NULL
Â«	NULL
Â»	NULL
ap	NULL
as	NULL
Â»	NULL
aa	NULL
Â»	NULL
as	NULL
Â»	NULL
cx	NULL
Â»	NULL
cu	NULL
Â»	NULL
<	NULL
-	NULL
ERK	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Activation	NULL
of	NULL
MEK	NULL
and	NULL
ERK/MAP	NULL
kinases	NULL
in	NULL
response	NULL
to	NULL
T-cell-tropic	NULL
gp120	NULL
or	NULL
anti-CD4	NULL
antibodies	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
preincubated	NULL
on	NULL
ice	NULL
for	NULL
60	NULL
min	NULL
with	NULL
recombinant	NULL
gp120	NULL
IIB	NULL
(	NULL
1	NULL
pg/ml	NULL
!	NULL
)	NULL

or	NULL
anti-CD4	NULL
(	NULL
Â«	NULL
-CD4	NULL
)	NULL
antibody	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
or	NULL
left	NULL
untreated	NULL
(	NULL
control	NULL
)	NULL
and	NULL
then	NULL
incubated	NULL
at	NULL
37Â°C	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
before	NULL
lysis	NULL
.	NULL

Proteins	NULL
(	NULL
50	NULL
pg	NULL
per	NULL
lane	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
phosphorylated	NULL
forms	NULL
of	NULL
MEK1/2	NULL
(	NULL
MEK-P	NULL
)	NULL
and	NULL
ERK1/2	NULL
(	NULL
ERK1/2-P	NULL
)	NULL
as	NULL
well	NULL
as	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
total	NULL
MEK	NULL
and	NULL
ERK	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
molecular	NULL
weight	NULL
markers	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
and	NULL
kinases	NULL
are	NULL
indicated	NULL
.	NULL

and	NULL
ERK1/2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

These	NULL
results	NULL
support	NULL
the	NULL
concept	NULL
that	NULL
HIV-1	NULL
binding	NULL
to	NULL
CD4	NULL
receptor	NULL
activates	NULL
the	NULL
expression	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
through	NULL
the	NULL
Raf-l-activated	NULL
MAP	NULL
kinase	NULL
pathway	NULL
.	NULL

Both	NULL
T-cell-tropic	NULL
and	NULL
macrophagetropic	NULL
HIV-1	NULL
can	NULL
activate	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
and	NULL
expression	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Although	NULL
results	NULL
obtained	NULL
with	NULL
anti-CD4	NULL
antibodies	NULL
show	NULL
that	NULL
CD4	NULL
receptor	NULL
alone	NULL
may	NULL
transduce	NULL
signals	NULL
required	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
cytokine/chemokine	NULL
genes	NULL
independently	NULL
of	NULL
chemokine	NULL
receptor	NULL
signaling	NULL
,	NULL
we	NULL
could	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
HIV-1	NULL
with	NULL
chemokine	NULL
coreceptors	NULL
and	NULL
subsequent	NULL
entry	NULL
of	NULL
the	NULL
virus	NULL
also	NULL
affect	NULL
cellular	NULL
signaling	NULL
and	NULL
modulate	NULL
the	NULL
expression	NULL
of	NULL
inflammatory	NULL
genes	NULL
.	NULL

We	NULL
therefore	NULL
analyzed	NULL
the	NULL
contribution	NULL
of	NULL
chemokine	NULL
receptor	NULL
occupancy	NULL
in	NULL
HIV-1-mediated	NULL
stimulation	NULL
of	NULL
inflammatory	NULL
gene	NULL
expression	NULL
.	NULL

By	NULL
RT-PCR	NULL
analysis	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
in	NULL
Jurkat	NULL
cells	NULL
expression	NULL
of	NULL
the	NULL
CCR5	NULL
gene	NULL
encoding	NULL
the	NULL
major	NULL
coreceptor	NULL
for	NULL
macrophagetropic	NULL
viruses	NULL
(	NULL
20	NULL
)	NULL
,	NULL
while	NULL
these	NULL
cells	NULL
expressed	NULL
CXCR4	NULL
,	NULL
a	NULL
major	NULL
coreceptor	NULL
for	NULL
T-cell-tropic	NULL
HIV-1	NULL
(	NULL
5	NULL
)	NULL
,	NULL
and	NULL
were	NULL
fully	NULL
permissive	NULL
for	NULL
the	NULL
infection	NULL
with	NULL
T-cell-tropic	NULL
HIV-1	NULL
NLA-3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
HIV-1	NULL
binding	NULL
to	NULL
a	NULL
chemokine	NULL
coreceptor	NULL
contributes	NULL
to	NULL
the	NULL
CD4-mediated	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
,	NULL
we	NULL
used	NULL
macrophagetropic	NULL
viruses	NULL
Ba-L	NULL
and	NULL
AD8	NULL
.	NULL

Since	NULL
CCRS	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
these	NULL
viruses	NULL
do	NULL
not	NULL
enter	NULL
and	NULL
infect	NULL
these	NULL
cells	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
inflammatory	NULL
genes	NULL
could	NULL
be	NULL
attributed	NULL
solely	NULL
to	NULL
the	NULL
interaction	NULL
of	NULL
the	NULL
HIV-1	NULL
with	NULL
the	NULL
CD4	NULL
receptor	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
binding	NULL
of	NULL
Ba-L	NULL
or	NULL
AD8	NULL
to	NULL
Jurkat	NULL
T	NULL
cells	NULL
significantly	NULL
upregulated	NULL
the	NULL
expression	NULL
of	NULL
TNF-	NULL
Â«	NULL
and	NULL
MIP-18	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
AD8	NULL
also	NULL
stimulated	NULL
the	NULL
HIV-1	NULL
SIGNALING	NULL
IN	NULL
INFLAMMATORY	NULL
GENE	NULL
EXPRESSION	NULL
-	NULL
6409	NULL
A	NULL
.	NULL

B.	NULL
p	NULL
3	NULL
2	NULL
Â£	NULL
3	NULL
&	NULL
Â§	NULL
.	NULL

E	NULL
E	NULL
n	NULL
2	NULL
4	NULL
2	NULL
_s	NULL
S	NULL
aA	NULL
5	NULL
<	NULL
<	NULL
-	NULL
IFNy	NULL
<	NULL
-	NULL
IFNy	NULL
<	NULL
TNFa	NULL
so-	NULL
Â»	NULL
<	NULL
-	NULL
TNFo	NULL
<	NULL
-	NULL
MIP-la	NULL
<	NULL
-	NULL
MIP-1a	NULL
wo	NULL
Â»	NULL
<	NULL
-	NULL
MIP-18B	NULL
<	NULL
-	NULL
MIP-18	NULL
waaay	NULL
wae	NULL
<	NULL
-	NULL
GAPDH	NULL
&	NULL
FasL	NULL
camp	NULL
ex	NULL
Â»	NULL
.	NULL

<	NULL
-	NULL
GAPDH	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Binding	NULL
of	NULL
macrophagetropic	NULL
viruses	NULL
to	NULL
CCRS-negative	NULL
Jurkat	NULL
T	NULL
cells	NULL
upregulates	NULL
expression	NULL
of	NULL
cytokine	NULL
,	NULL
chemokine	NULL
,	NULL
and	NULL
FasL	NULL
genes	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
3	NULL
h	NULL
at	NULL
37Â°C	NULL
with	NULL
sucrose	NULL
gradient-purified	NULL
Ba-L	NULL
(	NULL
A	NULL
)	NULL
or	NULL
AD8	NULL
(	NULL
B	NULL
)	NULL
virions	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
,	NULL
and	NULL
mRNA	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
RT-PCR	NULL
using	NULL
primers	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

GAPDH	NULL
served	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
resolved	NULL
on	NULL
2	NULL
%	NULL
agarose	NULL
gels	NULL
and	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

expression	NULL
of	NULL
Fas	NULL
ligand	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
stimulation	NULL
with	NULL
anti-CD4	NULL
antibody	NULL
,	NULL
binding	NULL
of	NULL
macrophagetropic	NULL
viruses	NULL
stimulated	NULL
the	NULL
expression	NULL
of	NULL
MIP-1	NULL
Â«	NULL
and	NULL
IFN-y	NULL
genes	NULL
much	NULL
less	NULL
effectively	NULL
.	NULL

Although	NULL
their	NULL
significance	NULL
is	NULL
unclear	NULL
,	NULL
these	NULL
differences	NULL
may	NULL
reflect	NULL
different	NULL
binding	NULL
affinities	NULL
of	NULL
HIV-1	NULL
and	NULL
anti-CD4	NULL
antibody	NULL
.	NULL

Carroll	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
Ba-L	NULL
binds	NULL
to	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
CCR5	NULL
and	NULL
viral	NULL
entry	NULL
,	NULL
substantiating	NULL
our	NULL
conclusion	NULL
that	NULL
virus	NULL
binding	NULL
to	NULL
CD4	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
experiments	NULL
have	NULL
not	NULL
excluded	NULL
,	NULL
however	NULL
,	NULL
the	NULL
possibility	NULL
that	NULL
macrophagetropic	NULL
viruses	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
receptor	NULL
(	NULL
s	NULL
)	NULL
of	NULL
the	NULL
CCR	NULL
family	NULL
present	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
37	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
by	NULL
T-cell-tropic	NULL
and	NULL
macrophagetropic	NULL
viruses	NULL
in	NULL
Jurkat	NULL
cells	NULL
correlates	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
levels	NULL
of	NULL
phosphorylated	NULL
and	NULL
activated	NULL
MEK1/2	NULL
and	NULL
ERK1/2	NULL
MAP	NULL
kinases	NULL
upon	NULL
binding	NULL
of	NULL
these	NULL
viruses	NULL
to	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
show	NULL
that	NULL
binding	NULL
of	NULL
both	NULL
NL4-3	NULL
and	NULL
Ba-L	NULL
strains	NULL
of	NULL
HIV-1	NULL
to	NULL
Jurkat	NULL
cells	NULL
results	NULL
in	NULL
fast	NULL
and	NULL
transient	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
both	NULL
MEK	NULL
and	NULL
ERK1/2	NULL
.	NULL

Similarly	NULL
,	NULL
activation	NULL
of	NULL
ERK2	NULL
by	NULL
HIV-1	NULL
LAI	NULL
was	NULL
shown	NULL
recently	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
however	NULL
,	NULL
MEK	NULL
and	NULL
ERK1/2	NULL
kinases	NULL
could	NULL
also	NULL
be	NULL
activated	NULL
upon	NULL
binding	NULL
of	NULL
the	NULL
natural	NULL
ligand	NULL
SDF-1	NULL
to	NULL
the	NULL
CXCR4	NULL
receptor	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
upon	NULL
binding	NULL
of	NULL
SDF-1	NULL
to	NULL
CXCR4	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
previously	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
by	NULL
gp120	NULL
or	NULL
HIV-1	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD4	NULL
that	NULL
associates	NULL
with	NULL
Lek	NULL
.	NULL

Since	NULL
the	NULL
binding	NULL
of	NULL
SDF-1	NULL
to	NULL
CXCR4	NULL
receptor	NULL
activated	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
we	NULL
needed	NULL
to	NULL
establish	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
observed	NULL
upon	NULL
binding	NULL
of	NULL
T-cell-tropic	NULL
gp120	NULL
IIIB	NULL
or	NULL
NLA4-3	NULL
is	NULL
mediated	NULL
by	NULL
CD4	NULL
or	NULL
CXCR4	NULL
receptors	NULL
.	NULL

We	NULL
have	NULL
used	NULL
A2.01/â¬CD4.401	NULL
cells	NULL
expressing	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
CD4	NULL
lacking	NULL
the	NULL
whole	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
receptor	NULL
(	NULL
4	NULL
)	NULL
and	NULL
therefore	NULL
unable	NULL
to	NULL
associate	NULL
with	NULL
Leck	NULL
and	NULL
induce	NULL
signaling	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
activated	NULL
MEK1/2	NULL
and	NULL
6410	NULL
POPIK	NULL
ET	NULL
AL	NULL
.	NULL

3	NULL
U	NULL
C	NULL
7	NULL
)	NULL
r	NULL
>	NULL
)	NULL
7	NULL
)	NULL
.	NULL

&	NULL
)	NULL
?	NULL
)	NULL

2	NULL
A	NULL
7	NULL
42	NULL
!	NULL

6	NULL
g	NULL
$	NULL
g	NULL
4	NULL
&	NULL
&	NULL
5	NULL
&	NULL
Z	NULL
a	NULL
4	NULL
&	NULL
&	NULL
93	NULL
67	NULL
wa	NULL
c	NULL
Â»	NULL
<	NULL
0	NULL
<	NULL
Â»	NULL
-	NULL
cae	NULL
<	NULL
MEK-P	NULL
Cur	NULL
cs	NULL
can	NULL
ca	NULL
Â»	NULL
can	NULL
cam	NULL
comm	NULL
FMEK	NULL
67	NULL
56	NULL
42	NULL
-	NULL
ue	NULL
~	NULL
ug	NULL
w=	NULL
CERK1/2-P	NULL
28	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Activation	NULL
of	NULL
MEK	NULL
and	NULL
ERK/MAP	NULL
kinases	NULL
in	NULL
response	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
T-cell-tropic	NULL
or	NULL
macrophagetropic	NULL
HIV-1	NULL
or	NULL
SDF-1	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
preincubated	NULL
on	NULL
ice	NULL
for	NULL
60	NULL
min	NULL
with	NULL
purified	NULL
virions	NULL
or	NULL
SDF-1	NULL
(	NULL
5	NULL
pg/ml	NULL
!	NULL
)	NULL

or	NULL
left	NULL
untreated	NULL
(	NULL
control	NULL
)	NULL
and	NULL
then	NULL
incubated	NULL
at	NULL
37Â°C	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
before	NULL
lysis	NULL
.	NULL

Proteins	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
phosphorylated	NULL
forms	NULL
of	NULL
MEK1/2	NULL
(	NULL
MEK-P	NULL
)	NULL
and	NULL
ERK1/2	NULL
(	NULL
ERK1/2-P	NULL
)	NULL
as	NULL
well	NULL
as	NULL
total	NULL
MEK	NULL
and	NULL
ERK	NULL
are	NULL
indicated	NULL
.	NULL

Sizes	NULL
are	NULL
indicated	NULL
in	NULL
kilodaltons	NULL
.	NULL

ERK1/2	NULL
MAP	NULL
kinase	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
shows	NULL
that	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
neither	NULL
anti-CD4	NULL
nor	NULL
gp120	NULL
IIIB	NULL
,	NULL
NL4-3	NULL
,	NULL
or	NULL
Ba-L.	NULL
antibodies	NULL
were	NULL
able	NULL
to	NULL
activate	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
.	NULL

Similarly	NULL
,	NULL
no	NULL
induction	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
upon	NULL
binding	NULL
of	NULL
NL4-3	NULL
,	NULL
Ba-L	NULL
,	NULL
or	NULL
anti-CD4	NULL
antibodies	NULL
could	NULL
be	NULL
detected	NULL
by	NULL
RT-PCR	NULL
analysis	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
SDF-1	NULL
ligand	NULL
,	NULL
however	NULL
,	NULL
activated	NULL
the	NULL
phosphorylation	NULL
of	NULL
MEK1/2	NULL
and	NULL
ERK1/2	NULL
in	NULL
these	NULL
cells	NULL
as	NULL
effectively	NULL
as	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
binding	NULL
of	NULL
T-cell-tropic	NULL
NL4-3	NULL
or	NULL
gp120	NULL
IIIB	NULL
to	NULL
the	NULL
CXCR4	NULL
receptor	NULL
does	NULL
not	NULL
activate	NULL
the	NULL
MEK/ERK	NULL
signal	NULL
transduction	NULL
pathway	NULL
as	NULL
does	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
natural	NULL
ligand	NULL
SDF-1	NULL
.	NULL

These	NULL
data	NULL
correlate	NULL
with	NULL
the	NULL
recent	NULL
results	NULL
of	NULL
others	NULL
,	NULL
who	NULL
have	NULL
shown	NULL
that	NULL
T-cell-tropic	NULL
gp160	NULL
derived	NULL
from	NULL
NLA-3	NULL
as	NULL
well	NULL
as	NULL
gp120	NULL
IIIB	NULL
did	NULL
not	NULL
induce	NULL
a	NULL
calcium	NULL
flux	NULL
in	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
59	NULL
)	NULL
.	NULL

SDF-1	NULL
neither	NULL
induces	NULL
nor	NULL
inhibits	NULL
HIV-1-stimulated	NULL
expression	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
in	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
a	NULL
chemokine	NULL
coreceptor	NULL
in	NULL
the	NULL
HIV-1-mediated	NULL
induction	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
binding	NULL
the	NULL
CXCR4	NULL
natural	NULL
ligand	NULL
,	NULL
SDF-1	NULL
,	NULL
on	NULL
T-cell-tropic	NULL
NL4-3	NULL
virus-mediated	NULL
cytokine	NULL
gene	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
NL4-3	NULL
to	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
expression	NULL
of	NULL
TNF-	NULL
Â«	NULL
and	NULL
MIP-18	NULL
genes	NULL
,	NULL
while	NULL
the	NULL
expression	NULL
of	NULL
MIP-1	NULL
Â«	NULL
and	NULL
IFN-y	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
was	NULL
undetectable	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
SDF-1	NULL
to	NULL
CXCR4	NULL
receptor	NULL
,	NULL
which	NULL
prevents	NULL
entry	NULL
of	NULL
T-cell	NULL
line-tropic	NULL
viruses	NULL
(	NULL
6	NULL
,	NULL
41	NULL
)	NULL
,	NULL
did	NULL
not	NULL
stimulate	NULL
transcription	NULL
of	NULL
these	NULL
genes	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
SDF-1	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
binding	NULL
of	NULL
SDF-1	NULL
to	NULL
CXCR4	NULL
receptor	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
expression	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
induced	NULL
by	NULL
NL4-3	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
SDF-1	NULL
on	NULL
CD4-mediated	NULL
signaling	NULL
was	NULL
not	NULL
restricted	NULL
to	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
binding	NULL
of	NULL
NL4-3	NULL
to	NULL
purified	NULL
CD4*	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
the	NULL
expression	NULL
of	NULL
TNF-	NULL
Â«	NULL
and	NULL
MIP-18	NULL
independently	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
SDF-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
J.	NULL
ViRoL	NULL
.	NULL

m	NULL
0	NULL
[	NULL
=	NULL
)	NULL
Ill	NULL
3	NULL
&	NULL
2	NULL
8	NULL
ki	NULL
NE	NULL
Mre	NULL
.	NULL

5	NULL
&	NULL
&	NULL
&	NULL
7	NULL
4	NULL
67	NULL
56	NULL
Jll	NULL
we	NULL
___	NULL
<	NULL
MEK-P	NULL
28	NULL
Â«	NULL
o	NULL
--	NULL
cme	NULL
Â«	NULL
me	NULL
Â«	NULL
me	NULL
cum	NULL
ome	NULL
.	NULL

<	NULL
-	NULL
MEK	NULL
67	NULL
56	NULL
-42-	NULL
e	NULL
Â«	NULL
-	NULL
ERK1/2-P	NULL
28	NULL
eapama	NULL
Â»	NULL
asana	NULL
Â»	NULL
.	NULL

-	NULL
ERK	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
MEK/ERK	NULL
kinase	NULL
pathway	NULL
by	NULL
T-cell-tropic	NULL
or	NULL
macrophagetropic	NULL
HIV-1	NULL
or	NULL
anti-CD4	NULL
antibody	NULL
depends	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD4	NULL
receptor	NULL
.	NULL

A2.01/â¬CD4.401	NULL
cells	NULL
expressing	NULL
truncated	NULL
CD4	NULL
receptors	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
control	NULL
)	NULL
or	NULL
preincubated	NULL
on	NULL
ice	NULL
for	NULL
60	NULL
min	NULL
with	NULL
SDF-1	NULL
(	NULL
5	NULL
pg/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
anti-CD4	NULL
antibody	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
,	NULL
gp120	NULL
IIIB	NULL
(	NULL
1	NULL
ug/m1	NULL
)	NULL
,	NULL
or	NULL
purified	NULL
NL4-3	NULL
or	NULL
Ba-L	NULL
(	NULL
5	NULL
RT	NULL
epm/cell	NULL
)	NULL
and	NULL
then	NULL
incubated	NULL
at	NULL
37Â°C	NULL
for	NULL
5	NULL
min	NULL
before	NULL
lysis	NULL
.	NULL

Proteins	NULL
(	NULL
50	NULL
g	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
phosphorylated	NULL
forms	NULL
of	NULL
MEK1/2	NULL
(	NULL
MEK-P	NULL
)	NULL
and	NULL
ERK1/2	NULL
(	NULL
ERK1/2-P	NULL
)	NULL
as	NULL
well	NULL
as	NULL
total	NULL
MEK	NULL
and	NULL
ERK	NULL
are	NULL
indicated	NULL
.	NULL

Sizes	NULL
are	NULL
indicated	NULL
in	NULL
kilodaltons	NULL
.	NULL

expected	NULL
,	NULL
binding	NULL
of	NULL
SDF-1	NULL
to	NULL
CXCR4	NULL
receptor	NULL
also	NULL
did	NULL
not	NULL
affect	NULL
stimulation	NULL
of	NULL
cytokine	NULL
genes	NULL
by	NULL
a	NULL
macrophagetropic	NULL
virus	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Since	NULL
SDF-1	NULL
was	NULL
able	NULL
to	NULL
block	NULL
NL4-3	NULL
infection	NULL
,	NULL
these	NULL
findings	NULL
clearly	NULL
demonstrate	NULL
that	NULL
induction	NULL
of	NULL
the	NULL
early	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
determined	NULL
primarily	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
the	NULL
HIV-1	NULL
envelope	NULL
with	NULL
CD4	NULL
receptor	NULL
and	NULL
that	NULL
viral	NULL
tropism	NULL
and/or	NULL
viral	NULL
entry	NULL
does	NULL
not	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
CD4-mediated	NULL
signaling	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
induction	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
affinity	NULL
of	NULL
HIV-1	NULL
binding	NULL
to	NULL
the	NULL
CD4	NULL
receptor	NULL
,	NULL
we	NULL
used	NULL
two	NULL
T-cell-tropic	NULL
NL4-3-derived	NULL
viruses	NULL
NL4-3	NULL
+	NULL
SDF-1	NULL
Ba-L	NULL
+	NULL
SDF-1	NULL
>	NULL
control	NULL
SDF-1	NULL
NL4-3	NULL
w	NULL
control	NULL
SDF-1	NULL
Ba-L	NULL
wwe	NULL
.	NULL

<	NULL
-	NULL
TNF-	NULL
ewes	NULL
.	NULL

mme	NULL
<	NULL
-	NULL
TNF-0	NULL
<	NULL
-	NULL
MIP-la	NULL
<	NULL
-	NULL
MIP-la	NULL
se	NULL
mee	NULL
o	NULL
Mipap	NULL
wo	NULL
Â»	NULL
amme	NULL
-	NULL
<	NULL
-	NULL
MIP-1G	NULL
cose	NULL
came	NULL
cmm	NULL
Â»	NULL
come	NULL
<	NULL
-	NULL
GAPDH	NULL
come	NULL
came	NULL
tamp	NULL
o	NULL
--	NULL
<	NULL
-	NULL
GAPDH	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

SDF-1	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
HIV-1-stimulated	NULL
expression	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
control	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
sucrose	NULL
gradient-purified	NULL
NL4-3	NULL
(	NULL
A	NULL
)	NULL
or	NULL
Ba-L	NULL
virions	NULL
(	NULL
B	NULL
)	NULL
,	NULL
SDF-1	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
HIV-1	NULL
and	NULL
SDF-1	NULL
.	NULL

After	NULL
3	NULL
h	NULL
at	NULL
37Â°C	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
expression	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
was	NULL
analyzed	NULL
by	NULL
RT-PCR	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

GAPDH	NULL
served	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

voL	NULL
.	NULL

72	NULL
,	NULL
1998	NULL
NL-D368E	NULL
NL-D3GSP	NULL
control	NULL
<	NULL
-	NULL
MIP-10	NULL
NL-D368E	NULL
NL-D3GSP	NULL
NL4-3	NULL
<	NULL
-	NULL
HIV-1	NULL
gp	NULL
120	NULL
cme	NULL
<	NULL
-	NULL
MIP-1	NULL
$	NULL
ââââ	NULL
&	NULL
GAPDH	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Induction	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
gene	NULL
expression	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
affinity	NULL
of	NULL
HIV-1	NULL
binding	NULL
to	NULL
CD4	NULL
receptor	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
levels	NULL
of	NULL
gp120	NULL
envelope	NULL
in	NULL
pelleted	NULL
virion	NULL
preparations	NULL
(	NULL
10Â°	NULL
RT	NULL
cpm	NULL
)	NULL
of	NULL
NL4-3	NULL
and	NULL
NL4-3-derived	NULL
clones	NULL
NL-D368E	NULL
and	NULL
NL-D368P	NULL
were	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
mouse	NULL
anti-gp120	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Binding	NULL
of	NULL
NL4-3	NULL
but	NULL
not	NULL
NL-D368E	NULL
and	NULL
NL-D368P	NULL
(	NULL
45	NULL
)	NULL
induced	NULL
expression	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Purified	NULL
virions	NULL
(	NULL
10Â°	NULL
RT	NULL
cpm	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
3	NULL
h	NULL
at	NULL
37Â°C	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
was	NULL
analyzed	NULL
by	NULL
RT-PCR	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

GAPDH	NULL
served	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

that	NULL
were	NULL
shown	NULL
to	NULL
have	NULL
a	NULL
significantly	NULL
reduced	NULL
CD4	NULL
binding	NULL
affinity	NULL
(	NULL
44	NULL
)	NULL
and	NULL
compared	NULL
their	NULL
abilities	NULL
to	NULL
induce	NULL
TNF-	NULL
Â«	NULL
and	NULL
MIP-18	NULL
gene	NULL
expression	NULL
with	NULL
that	NULL
of	NULL
NLA4-3	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
all	NULL
of	NULL
these	NULL
viral	NULL
preparations	NULL
used	NULL
in	NULL
experiments	NULL
contained	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
gp120	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
levels	NULL
of	NULL
gp120	NULL
in	NULL
pelleted	NULL
virions	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
fact	NULL
that	NULL
pelleted	NULL
virions	NULL
contained	NULL
similar	NULL
amounts	NULL
of	NULL
gp120	NULL
,	NULL
HIV-1	NULL
NL4-3	NULL
but	NULL
neither	NULL
clone	NULL
NL-D368E	NULL
nor	NULL
clone	NULL
NL-D368P	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
TNF-	NULL
Â«	NULL
or	NULL
MIP-18	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
HIV-1	NULL
to	NULL
induce	NULL
cytokine	NULL
gene	NULL
expression	NULL
is	NULL
also	NULL
determined	NULL
by	NULL
the	NULL
affinity	NULL
of	NULL
binding	NULL
of	NULL
HIV-1	NULL
virions	NULL
to	NULL
CD4	NULL
receptors	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
binding	NULL
of	NULL
HIV-1	NULL
envelope	NULL
glycoprotein	NULL
gp120	NULL
to	NULL
CD4	NULL
receptors	NULL
on	NULL
T	NULL
cells	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
ERK/MAP	NULL
kinase	NULL
pathway	NULL
and	NULL
induction	NULL
of	NULL
transcription	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
HIV-1	NULL
envelope	NULL
to	NULL
CD4	NULL
receptors	NULL
is	NULL
essential	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
early	NULL
inflammatory	NULL
genes	NULL
and	NULL
that	NULL
CXCR4	NULL
does	NULL
not	NULL
participate	NULL
in	NULL
this	NULL
signaling	NULL
.	NULL

First	NULL
,	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
that	NULL
neither	NULL
expressed	NULL
CCR5	NULL
nor	NULL
supported	NULL
replication	NULL
of	NULL
macrophagetropic	NULL
Ba-L	NULL
and	NULL
ADS	NULL
,	NULL
these	NULL
two	NULL
HIV-1	NULL
variants	NULL
were	NULL
still	NULL
able	NULL
to	NULL
activate	NULL
the	NULL
ERK/MAP	NULL
kinase	NULL
pathway	NULL
and	NULL
upregulate	NULL
expression	NULL
of	NULL
TNF-	NULL
Â«	NULL
and	NULL
MIP-18B	NULL
.	NULL

Second	NULL
,	NULL
neither	NULL
activation	NULL
of	NULL
the	NULL
ERK/	NULL
MAP	NULL
kinase	NULL
pathway	NULL
nor	NULL
induction	NULL
of	NULL
cytokine	NULL
genes	NULL
was	NULL
detected	NULL
in	NULL
cells	NULL
expressing	NULL
a	NULL
truncated	NULL
CD4	NULL
receptor	NULL
that	NULL
is	NULL
unable	NULL
to	NULL
associate	NULL
with	NULL
Lok	NULL
and	NULL
induce	NULL
cellular	NULL
signaling	NULL
.	NULL

However	NULL
,	NULL
since	NULL
the	NULL
extracellular	NULL
part	NULL
of	NULL
CD4	NULL
receptor	NULL
is	NULL
not	NULL
altered	NULL
,	NULL
these	NULL
cells	NULL
are	NULL
still	NULL
able	NULL
to	NULL
bind	NULL
HIV-1	NULL
and	NULL
support	NULL
HIV-1	NULL
replication	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
binding	NULL
of	NULL
SDF-1	NULL
,	NULL
a	NULL
natural	NULL
ligand	NULL
for	NULL
the	NULL
CXCR4	NULL
receptor	NULL
which	NULL
inhibits	NULL
replication	NULL
of	NULL
T-cell-tropic	NULL
HIV-1	NULL
NL4-3	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
CD4*	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
,	NULL
did	NULL
not	NULL
affect	NULL
HIV-1-mediated	NULL
activation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
downregulation	NULL
of	NULL
CCRS	NULL
coreceptors	NULL
that	NULL
prevented	NULL
entry	NULL
of	NULL
macrophage	NULL
HIV-1	NULL
SIGNALING	NULL
IN	NULL
INFLAMMATORY	NULL
GENE	NULL
EXPRESSION	NULL
-	NULL
6411	NULL
tropic	NULL
virus	NULL
into	NULL
CD4	NULL
*	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
virus	NULL
binding	NULL
is	NULL
in	NULL
accordance	NULL
with	NULL
our	NULL
results	NULL
.	NULL

These	NULL
data	NULL
strongly	NULL
indicate	NULL
the	NULL
critical	NULL
role	NULL
of	NULL
the	NULL
CD4-mediated	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
the	NULL
aberrant	NULL
expression	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
and	NULL
extend	NULL
previous	NULL
observations	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
HIV-1	NULL
envelope	NULL
glycoprotein	NULL
gp120	NULL
or	NULL
cross-linking	NULL
of	NULL
CD4	NULL
receptors	NULL
with	NULL
anti-CD4	NULL
antibodies	NULL
induces	NULL
synthesis	NULL
of	NULL
several	NULL
cytokines	NULL
,	NULL
including	NULL
TNF-	NULL
Â«	NULL
and	NULL
IFN-y	NULL
(	NULL
43	NULL
,	NULL
56	NULL
)	NULL
as	NULL
well	NULL
as	NULL
IL-10	NULL
(	NULL
53	NULL
)	NULL
and	NULL
IL-6	NULL
(	NULL
42	NULL
)	NULL
.	NULL

We	NULL
have	NULL
,	NULL
however	NULL
,	NULL
observed	NULL
quantitative	NULL
differences	NULL
between	NULL
the	NULL
levels	NULL
of	NULL
cytokines	NULL
induced	NULL
by	NULL
binding	NULL
of	NULL
anti-CD4	NULL
antibodies	NULL
and	NULL
different	NULL
envelope	NULL
mutants	NULL
of	NULL
T-cell-tropic	NULL
NL4-3	NULL
.	NULL

While	NULL
both	NULL
the	NULL
anti-CD4	NULL
antibody	NULL
and	NULL
wild-type	NULL
NLA4-3	NULL
stimulate	NULL
the	NULL
expression	NULL
of	NULL
TNF-	NULL
Â«	NULL
and	NULL
MIP-18	NULL
,	NULL
IFN-y	NULL
and	NULL
MIP-1	NULL
Â«	NULL
were	NULL
induced	NULL
more	NULL
effectively	NULL
by	NULL
anti-CD4	NULL
antibody	NULL
than	NULL
by	NULL
the	NULL
virus	NULL
.	NULL

Two	NULL
NLA-3-derived	NULL
clones	NULL
,	NULL
NL-D368E	NULL
and	NULL
NL-D368P	NULL
,	NULL
that	NULL
have	NULL
altered	NULL
CD4	NULL
binding	NULL
region	NULL
of	NULL
gp120	NULL
and	NULL
consequently	NULL
significantly	NULL
reduced	NULL
affinity	NULL
for	NULL
CD4	NULL
receptors	NULL
(	NULL
44	NULL
)	NULL
were	NULL
not	NULL
able	NULL
to	NULL
stimulate	NULL
transcription	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Since	NULL
the	NULL
infectivity	NULL
of	NULL
these	NULL
poorly	NULL
CD4	NULL
binding	NULL
virions	NULL
was	NULL
linearly	NULL
dependent	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
density	NULL
of	NULL
CD4	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
primary	NULL
HIV-1	NULL
isolates	NULL
to	NULL
induce	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
vivo	NULL
may	NULL
be	NULL
determined	NULL
both	NULL
by	NULL
the	NULL
affinity	NULL
of	NULL
viral	NULL
glycoproteins	NULL
for	NULL
CD4	NULL
and	NULL
by	NULL
the	NULL
number	NULL
of	NULL
CD4	NULL
receptors	NULL
.	NULL

Since	NULL
the	NULL
discovery	NULL
that	NULL
the	NULL
chemokine	NULL
receptors	NULL
that	NULL
belong	NULL
to	NULL
a	NULL
family	NULL
of	NULL
seven-transmembrane-domain	NULL
G-protein-coupled	NULL
receptors	NULL
serve	NULL
as	NULL
HIV-1	NULL
coreceptors	NULL
,	NULL
numerous	NULL
studies	NULL
have	NULL
addressed	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
the	NULL
signaling	NULL
pathway	NULL
mediated	NULL
by	NULL
these	NULL
receptors	NULL
is	NULL
required	NULL
for	NULL
viral	NULL
infectivity	NULL
.	NULL

All	NULL
of	NULL
these	NULL
studies	NULL
indicate	NULL
that	NULL
G-protein-mediated	NULL
signaling	NULL
and	NULL
intracellular	NULL
calcium	NULL
mobilization	NULL
are	NULL
not	NULL
required	NULL
for	NULL
HIV-1	NULL
membrane	NULL
fusion	NULL
and	NULL
entry	NULL
of	NULL
HIV-1	NULL
into	NULL
the	NULL
cells	NULL
(	NULL
3	NULL
,	NULL
23	NULL
,	NULL
29	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
to	NULL
uncouple	NULL
chemokine	NULL
recep-tor-mediated	NULL
signaling	NULL
from	NULL
its	NULL
ability	NULL
to	NULL
function	NULL
as	NULL
a	NULL
coreceptor	NULL
for	NULL
HIV-1	NULL
entry	NULL
suggests	NULL
that	NULL
internalization	NULL
of	NULL
HIV-1	NULL
proceeds	NULL
through	NULL
a	NULL
novel	NULL
mechanism	NULL
that	NULL
is	NULL
unrelated	NULL
to	NULL
the	NULL
signaling	NULL
function	NULL
of	NULL
these	NULL
receptors	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
data	NULL
from	NULL
our	NULL
laboratories	NULL
as	NULL
well	NULL
as	NULL
data	NULL
of	NULL
others	NULL
indicate	NULL
that	NULL
HIV-1	NULL
gp120	NULL
can	NULL
function	NULL
as	NULL
a	NULL
ligand	NULL
for	NULL
the	NULL
chemokine	NULL
receptors	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
gp120	NULL
IIIB	NULL
induces	NULL
migration	NULL
of	NULL
human	NULL
neurons	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
and	NULL
that	NULL
this	NULL
chemotactic	NULL
response	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
CXCR4-specific	NULL
antibodies	NULL
.	NULL

Furthermore	NULL
,	NULL
both	NULL
gp120	NULL
IIIB	NULL
and	NULL
SDF-1	NULL
can	NULL
directly	NULL
induce	NULL
apoptosis	NULL
in	NULL
human	NULL
neurons	NULL
(	NULL
reference	NULL
32	NULL
and	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
Weissman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
59	NULL
)	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
macrophagetropic	NULL
HIV-1	NULL
and	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
envelopes	NULL
mediate	NULL
signaling	NULL
through	NULL
CCRS	NULL
receptors	NULL
and	NULL
induce	NULL
chemotaxis	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
signaling	NULL
or	NULL
chemotaxis	NULL
was	NULL
observed	NULL
upon	NULL
binding	NULL
of	NULL
gp120	NULL
IIIB	NULL
from	NULL
T-cell-tropic	NULL
HIV-1	NULL
to	NULL
CXCR4	NULL
receptors	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
in	NULL
this	NULL
study	NULL
that	NULL
binding	NULL
of	NULL
SDF-1	NULL
ligand	NULL
to	NULL
CXCR4	NULL
receptor	NULL
stimulates	NULL
MEK/ERK	NULL
kinase	NULL
pathway	NULL
;	NULL
however	NULL
,	NULL
binding	NULL
of	NULL
neither	NULL
T-cell-tropic	NULL
NL4-3	NULL
virions	NULL
nor	NULL
gp120	NULL
IIIB	NULL
envelope	NULL
glycoprotein	NULL
could	NULL
induce	NULL
this	NULL
pathway	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
signaling	NULL
from	NULL
CD4	NULL
receptor	NULL
,	NULL
indicating	NULL
that	NULL
binding	NULL
of	NULL
gp120	NULL
and	NULL
SDF-1	NULL
to	NULL
CXCR4	NULL
does	NULL
not	NULL
necessarily	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
same	NULL
signaling	NULL
pathway	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

While	NULL
this	NULL
study	NULL
was	NULL
in	NULL
progress	NULL
,	NULL
Davis	NULL
et	NULL
al	NULL
.	NULL

(	NULL
19	NULL
)	NULL
showed	NULL
that	NULL
binding	NULL
of	NULL
SDF-1	NULL
and	NULL
RANTES	NULL
to	NULL
CXCR4	NULL
and	NULL
CCR5	NULL
,	NULL
respectively	NULL
,	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Pyk2	NULL
kinase	NULL
in	NULL
HL60	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
T-cell	NULL
clone	NULL
DUG6	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Pyk2	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
HL60	NULL
cells	NULL
after	NULL
addition	NULL
of	NULL
mono-meric	NULL
gp120	NULL
(	NULL
BH10	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
Pyk2	NULL
by	NULL
gp120	NULL
(	NULL
BH10	NULL
)	NULL
was	NULL
inhibited	NULL
by	NULL
pretreatment	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
to	NULL
CXCR4	NULL
or	NULL
by	NULL
pertussin	NULL
toxin	NULL
,	NULL
and	NULL
the	NULL
authors	NULL
concluded	NULL
that	NULL
6412	NULL
POPIK	NULL
ET	NULL
AL	NULL
.	NULL

for	NULL
activation	NULL
of	NULL
Pyk2	NULL
,	NULL
a	NULL
functional	NULL
G	NULL
protein	NULL
is	NULL
required	NULL
.	NULL

The	NULL
Pyk2	NULL
kinase	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
link	NULL
G-coupled	NULL
receptors	NULL
with	NULL
Grb	NULL
and	NULL
Sos	NULL
and	NULL
activate	NULL
MAP	NULL
kinase	NULL
in	NULL
PC12	NULL
cells	NULL
(	NULL
21	NULL
)	NULL
.	NULL

It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
see	NULL
whether	NULL
the	NULL
SDF-1-mediated	NULL
activation	NULL
of	NULL
Pyk2	NULL
can	NULL
be	NULL
linked	NULL
to	NULL
the	NULL
MAP	NULL
kinase	NULL
signaling	NULL
pathway	NULL
described	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
observed	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
only	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
functional	NULL
CD4	NULL
receptor	NULL
,	NULL
we	NULL
can	NULL
not	NULL
eliminate	NULL
the	NULL
possibility	NULL
that	NULL
gp120	NULL
derived	NULL
from	NULL
another	NULL
strain	NULL
of	NULL
HIV-1	NULL
,	NULL
which	NULL
may	NULL
bind	NULL
to	NULL
another	NULL
domain	NULL
of	NULL
the	NULL
CXCR4	NULL
receptor	NULL
(	NULL
8	NULL
,	NULL
39	NULL
,	NULL
54	NULL
)	NULL
,	NULL
will	NULL
activate	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
independently	NULL
of	NULL
CD4	NULL
signaling	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
under	NULL
way	NULL
to	NULL
explore	NULL
this	NULL
possibil-ity	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
Raf-1	NULL
and	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
by	NULL
binding	NULL
of	NULL
HIV-1	NULL
envelope	NULL
glycoproteins	NULL
to	NULL
CD4	NULL
receptors	NULL
leads	NULL
to	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
early	NULL
inflammatory	NULL
genes	NULL
.	NULL

We	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
T	NULL
cells	NULL
overexpressing	NULL
activated	NULL
Raf-1	NULL
support	NULL
replication	NULL
of	NULL
HIV-1	NULL
more	NULL
effectively	NULL
than	NULL
parental	NULL
cells	NULL
(	NULL
47	NULL
)	NULL
and	NULL
that	NULL
some	NULL
of	NULL
the	NULL
early	NULL
inflammatory	NULL
gene	NULL
products	NULL
such	NULL
as	NULL
TNF-	NULL
Â«	NULL
can	NULL
support	NULL
HIV-1	NULL
replication	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
HIV-1l-encoded	NULL
transactivator	NULL
Tat	NULL
(	NULL
46	NULL
)	NULL
.	NULL

These	NULL
data	NULL
altogether	NULL
suggest	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
cellular	NULL
signaling	NULL
pathways	NULL
that	NULL
lead	NULL
to	NULL
the	NULL
production	NULL
of	NULL
cytokine	NULL
and	NULL
chemokine	NULL
genes	NULL
is	NULL
used	NULL
by	NULL
the	NULL
virus	NULL
to	NULL
support	NULL
its	NULL
first	NULL
cycle	NULL
of	NULL
replication	NULL
that	NULL
occurs	NULL
before	NULL
the	NULL
Tat	NULL
transactivator	NULL
is	NULL
synthesized	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
by	NULL
binding	NULL
of	NULL
SDF-1	NULL
to	NULL
CXCR4	NULL
receptor	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
the	NULL
stimulation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
binding	NULL
of	NULL
HIV-1	NULL
envelope	NULL
glycoproteins	NULL
to	NULL
CD4	NULL
may	NULL
generate	NULL
a	NULL
second	NULL
signal	NULL
(	NULL
possibly	NULL
by	NULL
the	NULL
involvement	NULL
of	NULL
Lek	NULL
)	NULL
which	NULL
when	NULL
coupled	NULL
to	NULL
the	NULL
MAP	NULL
kinase	NULL
signaling	NULL
pathway	NULL
stimulates	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
early	NULL
inflammatory	NULL
genes	NULL
.	NULL

The	NULL
observations	NULL
that	NULL
over	NULL
99	NULL
%	NULL
of	NULL
plasma	NULL
virions	NULL
are	NULL
not	NULL
infectious	NULL
(	NULL
26	NULL
)	NULL
and	NULL
that	NULL
a	NULL
large	NULL
amount	NULL
of	NULL
HIV-1	NULL
virions	NULL
are	NULL
associated	NULL
with	NULL
follicular	NULL
dendritic	NULL
cells	NULL
in	NULL
lymphoid	NULL
tissues	NULL
(	NULL
31	NULL
)	NULL
,	NULL
where	NULL
they	NULL
come	NULL
in	NULL
contact	NULL
with	NULL
migrating	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
suggest	NULL
that	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
may	NULL
become	NULL
aberrantly	NULL
activated	NULL
.	NULL

It	NULL
was	NULL
also	NULL
shown	NULL
recently	NULL
(	NULL
49	NULL
)	NULL
that	NULL
HIV-1	NULL
antigens	NULL
,	NULL
including	NULL
gp160	NULL
,	NULL
stimulate	NULL
production	NULL
of	NULL
IFN-y	NULL
,	NULL
RANTES	NULL
,	NULL
and	NULL
MIP-1	NULL
in	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
from	NULL
individuals	NULL
chronically	NULL
infected	NULL
with	NULL
HIV-1	NULL
,	NULL
which	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
augmentation	NULL
of	NULL
humoral	NULL
immune	NULL
response	NULL
and	NULL
control	NULL
of	NULL
viremia	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
both	NULL
T-cell-tropic	NULL
and	NULL
macrophagetropic	NULL
HIV-1	NULL
envelope	NULL
glycoproteins	NULL
with	NULL
CD4	NULL
receptors	NULL
can	NULL
,	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
HIV-1	NULL
entry	NULL
and	NULL
replication	NULL
,	NULL
result	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
signal	NULL
transduction	NULL
pathways	NULL
and	NULL
the	NULL
aberrant	NULL
production	NULL
of	NULL
cytokines	NULL
and	NULL
chemokines	NULL
and	NULL
contribute	NULL
significantly	NULL
to	NULL
the	NULL
replicative	NULL
ability	NULL
of	NULL
HIV-1	NULL
variants	NULL
as	NULL
well	NULL
as	NULL
to	NULL
a	NULL
modulation	NULL
of	NULL
the	NULL
immune	NULL
responses	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
D.	NULL
Kabat	NULL
for	NULL
the	NULL
NL-D368E	NULL
and	NULL
NL-D368P	NULL
HIV-1	NULL
clones	NULL
,	NULL
F.	NULL
Maldarelli	NULL
for	NULL
ADS	NULL
HIV-1	NULL
,	NULL
S.	NULL
Gartner	NULL
for	NULL
Ba-L	NULL
HIV-1	NULL
,	NULL
and	NULL
K.-T.	NULL
Jeang	NULL
for	NULL
A2.01/â¬CD4.401	NULL
cells	NULL
.	NULL

This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
AI26123	NULL
and	NULL
AI40838	NULL
to	NULL
P.M.P	NULL
.	NULL

and	NULL
AI42557	NULL
to	NULL
W.P	NULL
.	NULL
)	NULL

.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Amara	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
L.	NULL
Gall	NULL
,	NULL
O.	NULL
Schwartz	NULL
,	NULL
J.	NULL
Salamero	NULL
,	NULL
M.	NULL
Montes	NULL
,	NULL
P.	NULL
Loetscher	NULL
,	NULL
M.	NULL
Baggiolini	NULL
,	NULL
J.	NULL
L.	NULL
Virelizier	NULL
,	NULL
and	NULL
F.	NULL
Arenzana-Seisdedos	NULL
.	NULL

1997	NULL
.	NULL

HIV	NULL
coreceptor	NULL
downregulation	NULL
as	NULL
antiviral	NULL
principle	NULL
:	NULL
SDF-1	NULL
alpha-dependent	NULL
internalization	NULL
of	NULL
the	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
contributes	NULL
to	NULL
inhibition	NULL
of	NULL
HIV	NULL
replication	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:139-146	NULL
.	NULL

2	NULL
.	NULL

Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
L.	NULL
Virelizier	NULL
,	NULL
D.	NULL
Rousset	NULL
,	NULL
L.	NULL
Clark-Lewis	NULL
,	NULL
P.	NULL
Loetscher	NULL
,	NULL
B.	NULL
Moser	NULL
,	NULL
and	NULL
M.	NULL
Baggiolini	NULL
.	NULL

1996	NULL
.	NULL

HIV	NULL
blocked	NULL
by	NULL
chemokine	NULL
antagonist	NULL
.	NULL

Nature	NULL
383:400	NULL
.	NULL

3	NULL
.	NULL

Atchison	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
J.	NULL
Gosling	NULL
,	NULL
F.	NULL
S.	NULL
Monteclaro	NULL
,	NULL
C.	NULL
Franci	NULL
,	NULL
L.	NULL
Digilio	NULL
,	NULL
I.	NULL
F.	NULL
Charo	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Goldsmith	NULL
.	NULL

1996	NULL
.	NULL

Multiple	NULL
extracellular	NULL
elements	NULL
of	NULL
CCRS	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

and	NULL
HIV-1	NULL
entry	NULL
:	NULL
dissociation	NULL
from	NULL
response	NULL
to	NULL
chemokines	NULL
.	NULL

Science	NULL
274	NULL
:	NULL
1924-1926.	NULL
.	NULL

Benkirane	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Schmid-Antomarchi	NULL
,	NULL
D.	NULL
R.	NULL
Littman	NULL
,	NULL
M.	NULL
Hirn	NULL
,	NULL
B.	NULL
Rossi	NULL
,	NULL
and	NULL
C.	NULL
Devaux	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
CD4	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
replication	NULL
by	NULL
antibodies	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
immunoglobulin	NULL
CDR3-like	NULL
region	NULL
in	NULL
domain	NULL
1	NULL
of	NULL
CD4	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:6904-6910.	NULL
.	NULL

Berson	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
D.	NULL
Long	NULL
,	NULL
B.	NULL
J.	NULL
Doranz	NULL
,	NULL
J.	NULL
Rucker	NULL
,	NULL
F.	NULL
R.	NULL
Jirik	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Doms	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
seven-transmembrane	NULL
domain	NULL
receptor	NULL
involved	NULL
in	NULL
fusion	NULL
and	NULL
entry	NULL
of	NULL
T-cell-tropic	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
strains	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70	NULL
:	NULL
6288-6295.	NULL
.	NULL

Bleul	NULL
,	NULL
C.	NULL
C	NULL
,	NULL
,	NULL
M.	NULL
Farzan	NULL
,	NULL
H.	NULL
Choe	NULL
,	NULL
C.	NULL
Parolin	NULL
,	NULL
I.	NULL
Clark-Lewis	NULL
,	NULL
J.	NULL
Sodroski	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Springer	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
lymphocyte	NULL
chemoattractant	NULL
SDF-1	NULL
is	NULL
a	NULL
ligand	NULL
for	NULL
LESTR/fusin	NULL
and	NULL
blocks	NULL
HIV-1	NULL
entry	NULL
.	NULL

Nature	NULL
382:829-833.	NULL
.	NULL

Breen	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
A.	NULL
R.	NULL
Rezai	NULL
,	NULL
K.	NULL
Nakajima	NULL
,	NULL
G.	NULL
N.	NULL
Beall	NULL
,	NULL
R.	NULL
T.	NULL
Mitsuyasu	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
O.	NULL
Martinez-Maza	NULL
.	NULL

1990	NULL
.	NULL

Infection	NULL
with	NULL
HIV	NULL
is	NULL
associated	NULL
with	NULL
elevated	NULL
IL-6	NULL
levels	NULL
and	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:480-484.	NULL
.	NULL

Brelot	NULL
,	NULL
A.	NULL
,	NULL
N.	NULL
Heveker	NULL
,	NULL
O.	NULL
Pleskoff	NULL
,	NULL
N.	NULL
Sol	NULL
,	NULL
and	NULL
M.	NULL
Alizon	NULL
.	NULL

1997	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
first	NULL
and	NULL
third	NULL
extracellular	NULL
domains	NULL
of	NULL
CXCR-4	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
coreceptor	NULL
activity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:4744-4751.	NULL
.	NULL

Briant	NULL
,	NULL
L.	NULL
,	NULL
N.	NULL
Coudronniere	NULL
,	NULL
V.	NULL
Robert-Hebmann	NULL
,	NULL
M.	NULL
Benkirane	NULL
,	NULL
and	NULL
C.	NULL
Devaux	NULL
.	NULL

1996	NULL
.	NULL

Binding	NULL
of	NULL
HIV-1	NULL
virions	NULL
or	NULL
gp120-anti-gp120	NULL
immune	NULL
complexes	NULL
to	NULL
HIV-1-infected	NULL
quiescent	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
reveals	NULL
latent	NULL
infection	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:3994-4004	NULL
.	NULL

Buonaguro	NULL
,	NULL
L.	NULL
,	NULL
G.	NULL
Barillari	NULL
,	NULL
H.	NULL
K.	NULL
Chang	NULL
,	NULL
C.	NULL
A.	NULL
Bohan	NULL
,	NULL
V.	NULL
Kao	NULL
,	NULL
R.	NULL
Morgan	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
B.	NULL
Ensoli	NULL
.	NULL

1992	NULL
.	NULL

Effects	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Tat	NULL
protein	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:7159-7167	NULL
.	NULL

Carroll	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
J.	NULL
L.	NULL
Riley	NULL
,	NULL
B.	NULL
L.	NULL
Levine	NULL
,	NULL
Y.	NULL
Feng	NULL
,	NULL
S.	NULL
Kaushal	NULL
,	NULL
D.	NULL
W.	NULL
Ritchey	NULL
,	NULL
W.	NULL
Bernstein	NULL
,	NULL
O.	NULL
S.	NULL
Weislow	NULL
,	NULL
C.	NULL
R.	NULL
Brown	NULL
,	NULL
E.	NULL
A.	NULL
Berger	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
St.	NULL
Louis	NULL
.	NULL

1997	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
HIV-1	NULL
fusion	NULL
cofactor	NULL
expression	NULL
by	NULL
CD28	NULL
costimulation	NULL
of	NULL
CD4+	NULL
T	NULL
cells	NULL
.	NULL

Science	NULL
276:273-276	NULL
.	NULL

Center	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
H.	NULL
Kornfeld	NULL
,	NULL
and	NULL
W.	NULL
W.	NULL
Cruikshank	NULL
.	NULL

1996	NULL
.	NULL

Interleukin	NULL
16	NULL
and	NULL
its	NULL
function	NULL
as	NULL
a	NULL
CD4	NULL
ligand	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
17:476-481	NULL
.	NULL

Chirmule	NULL
,	NULL
N.	NULL
,	NULL
H.	NULL
Goonewardena	NULL
,	NULL
S.	NULL
Pabwa	NULL
,	NULL
R.	NULL
Pasieka	NULL
,	NULL
V.	NULL
S.	NULL
Kalyanaraman	NULL
,	NULL
and	NULL
S.	NULL
Pahwa	NULL
.	NULL

1995	NULL
.	NULL

HIV-1	NULL
envelope	NULL
glycoproteins	NULL
induce	NULL
activation	NULL
of	NULL
activated	NULL
protein-1	NULL
in	NULL
CD4+	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:19364-19369	NULL
.	NULL

Chirmule	NULL
,	NULL
N.	NULL
,	NULL
N.	NULL
Oyaizu	NULL
,	NULL
C.	NULL
Saxinger	NULL
,	NULL
and	NULL
S.	NULL
Pahwa	NULL
.	NULL

1994	NULL
.	NULL

Nef	NULL
protein	NULL
of	NULL
HIV-1	NULL
has	NULL
B-cell	NULL
stimulatory	NULL
activity	NULL
.	NULL

AIDS	NULL
8:733-734	NULL
.	NULL

Chirmule	NULL
,	NULL
N.	NULL
,	NULL
V.	NULL
S.	NULL
Kalyanaraman	NULL
,	NULL
and	NULL
S.	NULL
Pahwa	NULL
.	NULL

1994	NULL
.	NULL

Signals	NULL
transduced	NULL
through	NULL
the	NULL
CD4	NULL
molecule	NULL
on	NULL
T	NULL
lymphocytes	NULL
activate	NULL
NF-kB	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

203:498-505	NULL
.	NULL

Cocchi	NULL
,	NULL
F.	NULL
,	NULL
A.	NULL
L.	NULL
DeVico	NULL
,	NULL
A.	NULL
Garzino-Demo	NULL
,	NULL
S.	NULL
K.	NULL
Arya	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
P.	NULL
Lusso	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
of	NULL
RANTES	NULL
,	NULL
MIP-1	NULL
Â«	NULL
,	NULL
and	NULL
MIP-16	NULL
as	NULL
the	NULL
major	NULL
HIV-suppressive	NULL
factors	NULL
produced	NULL
by	NULL
CD8+	NULL
T	NULL
cells	NULL
.	NULL

Science	NULL
270:1811-1815	NULL
.	NULL

Collette	NULL
,	NULL
Y.	NULL
,	NULL
H.	NULL
Dutartre	NULL
,	NULL
A.	NULL
Benziane	NULL
,	NULL
Ramos-Morales	NULL
,	NULL
R.	NULL
Benarous	NULL
,	NULL
M.	NULL
Harris	NULL
,	NULL
and	NULL
D.	NULL
Olive	NULL
.	NULL

1996	NULL
.	NULL

Physical	NULL
and	NULL
functional	NULL
interaction	NULL
of	NULL
Nef	NULL
with	NULL
Lck	NULL
.	NULL

HIV-1	NULL
Nef-induced	NULL
T-cell	NULL
signaling	NULL
defects	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

15:6333-6341	NULL
.	NULL

Cruikshank	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
D.	NULL
M.	NULL
Center	NULL
,	NULL
N.	NULL
Nisar	NULL
,	NULL
M.	NULL
Wu	NULL
,	NULL
B.	NULL
Natke	NULL
,	NULL
A.	NULL
C.	NULL
Theodore	NULL
,	NULL
and	NULL
H.	NULL
Kornfeld	NULL
.	NULL

1994	NULL
.	NULL

Molecular	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
a	NULL
lymphocyte	NULL
chemoattractant	NULL
factor	NULL
:	NULL
association	NULL
of	NULL
biologic	NULL
function	NULL
with	NULL
CD4	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:5109-5113	NULL
.	NULL

Davis	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
I.	NULL
Dikic	NULL
,	NULL
D.	NULL
Unutmaz	NULL
,	NULL
C.	NULL
M.	NULL
Hill	NULL
,	NULL
J.	NULL
Arthos	NULL
,	NULL
M.	NULL
A.	NULL
Siani	NULL
,	NULL
D.	NULL
A.	NULL
Thompson	NULL
,	NULL
J.	NULL
Schlessinger	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1997	NULL
.	NULL

Signal	NULL
transduction	NULL
due	NULL
to	NULL
HIV-1	NULL
envelope	NULL
interactions	NULL
with	NULL
chemokine	NULL
receptors	NULL
CXCR4	NULL
or	NULL
CCRS	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:1793-1798	NULL
.	NULL

Deng	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Liu	NULL
,	NULL
W.	NULL
Ellmeier	NULL
,	NULL
S.	NULL
Choe	NULL
,	NULL
D.	NULL
Unutmaz	NULL
,	NULL
M.	NULL
Burkbart	NULL
,	NULL
P.	NULL
Di	NULL
Marzio	NULL
,	NULL
S.	NULL
Marmon	NULL
,	NULL
R.	NULL
E.	NULL
Sutton	NULL
,	NULL
C.	NULL
M.	NULL
Hill	NULL
,	NULL
C.	NULL
B.	NULL
Davis	NULL
,	NULL
S.	NULL
C.	NULL
Peiper	NULL
,	NULL
T.	NULL
J.	NULL
Schall	NULL
,	NULL
D.	NULL
R.	NULL
Littman	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Landau	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
major	NULL
co-receptor	NULL
for	NULL
primary	NULL
isolates	NULL
of	NULL
HIV-1	NULL
.	NULL

Nature	NULL
381:661-666	NULL
.	NULL

Dikic	NULL
,	NULL
L.	NULL
,	NULL
G.	NULL
Tokiwa	NULL
,	NULL
S.	NULL
Ley	NULL
,	NULL
S.	NULL
A.	NULL
Courtneidge	NULL
,	NULL
and	NULL
J.	NULL
Schlessinger	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
role	NULL
for	NULL
Pyk2	NULL
and	NULL
Src	NULL
in	NULL
linking	NULL
G-protein-coupled	NULL
receptors	NULL
with	NULL
MAP	NULL
kinase	NULL
activation	NULL
.	NULL

Nature	NULL
383:547-550	NULL
.	NULL

Emilie	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
Peuchmaur	NULL
,	NULL
M.	NULL
C.	NULL
Maillot	NULL
,	NULL
M.	NULL
C.	NULL
Crevon	NULL
,	NULL
N.	NULL
Brousse	NULL
,	NULL
J.	NULL
F.	NULL
Delfraissy	NULL
,	NULL
J.	NULL
Dormont	NULL
,	NULL
and	NULL
P.	NULL
Galanaud	NULL
.	NULL

1990	NULL
.	NULL

Production	NULL
of	NULL
interleukins	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus-1-replicating	NULL
lymph	NULL
nodes	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

86:148-159	NULL
.	NULL

Farzan	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Choe	NULL
,	NULL
K.	NULL
A.	NULL
Martin	NULL
,	NULL
Y	NULL
.	NULL

Sun	NULL
,	NULL
M.	NULL
Sidelko	NULL
,	NULL
C.	NULL
R.	NULL
Mackay	NULL
,	NULL
N.	NULL
P.	NULL
Gerard	NULL
,	NULL
J.	NULL
Sodroski	NULL
,	NULL
and	NULL
C.	NULL
Gerard	NULL
.	NULL

1997	NULL
.	NULL

HIV-1	NULL
entry	NULL
and	NULL
macrophage	NULL
inflammatory	NULL
protein-1B-mediated	NULL
signaling	NULL
are	NULL
independent	NULL
functions	NULL
of	NULL
the	NULL
chemokine	NULL
receptor	NULL
CCRS	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:6854-6857	NULL
.	NULL

Fauci	NULL
,	NULL
A.	NULL
S.	NULL
1993	NULL
.	NULL

Multifactorial	NULL
nature	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
disease	NULL
:	NULL
implications	NULL
for	NULL
therapy	NULL
.	NULL

Science	NULL
262:1011-1018.	NULL
.	NULL

Fauci	NULL
,	NULL
A	NULL
.	NULL

$	NULL
.	NULL

1996	NULL
.	NULL

Host	NULL
factors	NULL
and	NULL
the	NULL
pathogenesis	NULL
of	NULL
HIV-induced	NULL
disease	NULL
.	NULL

Nature	NULL
384:529-534	NULL
.	NULL

Finkel	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
G.	NULL
Tudor-Williams	NULL
,	NULL
N.	NULL
K.	NULL
Banda	NULL
,	NULL
M.	NULL
F.	NULL
Cotton	NULL
,	NULL
T.	NULL
Curiel	NULL
,	NULL
C.	NULL
Monks	NULL
,	NULL
T.	NULL
W.	NULL
Baba	NULL
,	NULL
R.	NULL
M.	NULL
Ruprecht	NULL
,	NULL
and	NULL
A.	NULL
Kupfer	NULL
.	NULL

1995	NULL
.	NULL

Apoptosis	NULL
occurs	NULL
predominantly	NULL
in	NULL
bystander	NULL
cells	NULL
and	NULL
not	NULL
in	NULL
productively	NULL
infected	NULL
cells	NULL
of	NULL
HIV-	NULL
and	NULL
SIV-infected	NULL
lymph	NULL
nodes	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

1:129-134	NULL
.	NULL

Fuchs	NULL
,	NULL
D.	NULL
,	NULL
A.	NULL
Hausen	NULL
,	NULL
G.	NULL
Reibnegger	NULL
,	NULL
E.	NULL
R.	NULL
Werner	NULL
,	NULL
G.	NULL
Werner-Felmayer	NULL
,	NULL
voL	NULL
.	NULL

72	NULL
,	NULL
1998	NULL
28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

M.	NULL
P.	NULL
Dierich	NULL
,	NULL
and	NULL
H.	NULL
Wachter	NULL
.	NULL

1989	NULL
.	NULL

Interferon-y	NULL
concentration	NULL
are	NULL
increased	NULL
in	NULL
sera	NULL
from	NULL
individuals	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J	NULL
.	NULL

Acquired	NULL
Immune	NULL
Defic	NULL
.	NULL

Syndr	NULL
.	NULL

2:158-162	NULL
.	NULL

Gartner	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
Markovits	NULL
,	NULL
D.	NULL
M.	NULL
Markovitz	NULL
,	NULL
M.	NULL
H.	NULL
Kaplan	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
M.	NULL
Popovie	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
role	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
in	NULL
HTLV-III/LAV	NULL
infection	NULL
.	NULL

Science	NULL
233:215-219	NULL
.	NULL

Gosling	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
S.	NULL
Monteclaro	NULL
,	NULL
R.	NULL
E.	NULL
Atchison	NULL
,	NULL
H.	NULL
Arai	NULL
,	NULL
C.	NULL
L.	NULL
Tsou	NULL
,	NULL
M.	NULL
A.	NULL
Goldsmith	NULL
,	NULL
and	NULL
I.	NULL
F.	NULL
Charo	NULL
.	NULL

1997	NULL
.	NULL

Molecular	NULL
uncoupling	NULL
of	NULL
C-C	NULL
chemokine	NULL
receptor	NULL
5-induced	NULL
chemotaxis	NULL
and	NULL
signal	NULL
transduction	NULL
from	NULL
HIV-1	NULL
coreceptor	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:5061-5066	NULL
.	NULL

Greenway	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Azad	NULL
,	NULL
J	NULL
.	NULL

Mills	NULL
,	NULL
and	NULL
D.	NULL
McPhee	NULL
.	NULL

1996	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Nef	NULL
binds	NULL
directly	NULL
to	NULL
Lek	NULL
and	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
,	NULL
inhibiting	NULL
kinase	NULL
activity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:6701-6708	NULL
.	NULL

Heath	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
J.	NULL
G.	NULL
Tew	NULL
,	NULL
A.	NULL
K.	NULL
Szakal	NULL
,	NULL
and	NULL
G.	NULL
F.	NULL
Burton	NULL
.	NULL

1995	NULL
.	NULL

Follicular	NULL
dendritic	NULL
cells	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
infectivity	NULL
.	NULL

Nature	NULL
377	NULL
:	NULL
740-744	NULL
.	NULL

Hesselgesser	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Halks-Miller	NULL
,	NULL
V.	NULL
DeVecchio	NULL
,	NULL
S.	NULL
C.	NULL
Peiper	NULL
,	NULL
J.	NULL
Hoxie	NULL
,	NULL
D.	NULL
L.	NULL
Kolson	NULL
,	NULL
D.	NULL
Taub	NULL
,	NULL
and	NULL
R.	NULL
Horuk	NULL
,	NULL
1997	NULL
.	NULL

CD4-independent	NULL
association	NULL
between	NULL
HIV-1	NULL
gp120	NULL
and	NULL
CXCR4	NULL
:	NULL
functional	NULL
chemokine	NULL
receptors	NULL
are	NULL
expressed	NULL
in	NULL
human	NULL
neurons	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

7:112-121	NULL
.	NULL

Kabat	NULL
,	NULL
D.	NULL
,	NULL
S.	NULL
L.	NULL
Kozak	NULL
,	NULL
K.	NULL
Wehrly	NULL
,	NULL
and	NULL
B.	NULL
Chasebro	NULL
.	NULL

1994	NULL
.	NULL

Differences	NULL
in	NULL
CD4	NULL
dependence	NULL
for	NULL
infection	NULL
of	NULL
laboratory-adapted	NULL
and	NULL
primary	NULL
patient	NULL
isolates	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:2570-2577	NULL
.	NULL

Kozak	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
E.	NULL
J.	NULL
Platt	NULL
,	NULL
N.	NULL
Madani	NULL
,	NULL
F.	NULL
E.	NULL
Ferro	NULL
,	NULL
Jr.	NULL
,	NULL
K.	NULL
Peden	NULL
,	NULL
and	NULL
D.	NULL
Kabat	NULL
.	NULL

1997	NULL
.	NULL

CD4	NULL
,	NULL
CXCR-4	NULL
,	NULL
and	NULL
CCR-5	NULL
dependencies	NULL
for	NULL
infections	NULL
by	NULL
primary	NULL
patient	NULL
and	NULL
laboratory-adapted	NULL
isolates	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:873-882	NULL
.	NULL

Lahdevirta	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
P.	NULL
Maury	NULL
,	NULL
A.	NULL
M.	NULL
Teppo	NULL
,	NULL
and	NULL
H.	NULL
Repo	NULL
.	NULL

1988	NULL
.	NULL

Elevated	NULL
levels	NULL
of	NULL
circulating	NULL
cachectin/tumor	NULL
necrosis	NULL
factor	NULL
in	NULL
patients	NULL
with	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

85:289-291	NULL
.	NULL

Lee	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
B.	NULL
Leung	NULL
,	NULL
M.	NULL
A.	NULL
Lemmon	NULL
,	NULL
J.	NULL
Zheng	NULL
,	NULL
D.	NULL
Cowburn	NULL
,	NULL
J.	NULL
Kuriyan	NULL
,	NULL
and	NULL
K.	NULL
Saksela	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
single	NULL
amino	NULL
acid	NULL
in	NULL
the	NULL
SH3	NULL
domain	NULL
of	NULL
Heck	NULL
determines	NULL
its	NULL
high	NULL
affinity	NULL
and	NULL
specificity	NULL
in	NULL
binding	NULL
to	NULL
HIV-1	NULL
Nef	NULL
protein	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:5006-5015	NULL
.	NULL

Liao	NULL
,	NULL
F.	NULL
,	NULL
G.	NULL
Alkhatib	NULL
,	NULL
K.	NULL
W.	NULL
C.	NULL
Peden	NULL
,	NULL
G.	NULL
Sharma	NULL
,	NULL
E.	NULL
A.	NULL
Berger	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Farber	NULL
.	NULL

1997	NULL
.	NULL

STRL33	NULL
,	NULL
a	NULL
novel	NULL
chemokine	NULL
receptor-like	NULL
protein	NULL
,	NULL
functions	NULL
as	NULL
a	NULL
fusion	NULL
cofactor	NULL
for	NULL
both	NULL
macrophage-tropic	NULL
and	NULL
T	NULL
cell	NULL
line-tropic	NULL
HIV-1	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:2015-2023	NULL
.	NULL

Luo	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
J.	NULL
V.	NULL
Garcia	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
association	NULL
of	NULL
Nef	NULL
with	NULL
a	NULL
cellular	NULL
serine/threonine	NULL
kinase	NULL
and	NULL
its	NULL
enhancement	NULL
of	NULL
infectivity	NULL
are	NULL
viral	NULL
isolate	NULL
dependent	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:6493-6496	NULL
.	NULL

McKnight	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
Wilkinson	NULL
,	NULL
G.	NULL
Simmons	NULL
,	NULL
S.	NULL
Talbot	NULL
,	NULL
L.	NULL
Picard	NULL
,	NULL
M.	NULL
Abuja	NULL
,	NULL
M.	NULL
Marsh	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Hoxie	NULL
,	NULL
and	NULL
P.	NULL
R.	NULL
Clapham	NULL
.	NULL

1997	NULL
.	NULL

Inhibition	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
fusion	NULL
by	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
a	NULL
coreceptor	NULL
(	NULL
CXCR4	NULL
)	NULL
is	NULL
both	NULL
cell	NULL
type	NULL
and	NULL
virus	NULL
strain	NULL
dependent	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:1692-1696	NULL
.	NULL

Nunn	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Marsh	NULL
.	NULL

1996	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Nef	NULL
associates	NULL
with	NULL
a	NULL
member	NULL
of	NULL
the	NULL
p21-activated	NULL
kinase	NULL
family	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:6157-6161	NULL
.	NULL

Oberlin	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Amara	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
C.	NULL
Bessia	NULL
,	NULL
J.	NULL
L.	NULL
Virelizier	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
O.	NULL
Schwartz	NULL
,	NULL
J.	NULL
M.	NULL
Heard	NULL
,	NULL
I.	NULL
Clark-Lewis	NULL
,	NULL
D.	NULL
F.	NULL
Legler	NULL
,	NULL
M.	NULL
Loetscher	NULL
,	NULL
M.	NULL
Baggiolini	NULL
,	NULL
and	NULL
B.	NULL
Moser	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
CXC	NULL
chemokine	NULL
SDF-1	NULL
is	NULL
the	NULL
ligand	NULL
for	NULL
LESTR/fusin	NULL
and	NULL
prevents	NULL
infection	NULL
by	NULL
T-cell-linc-adapted	NULL
HIV-1	NULL
.	NULL

Nature	NULL
382:833-835	NULL
.	NULL

Oyaizu	NULL
,	NULL
N.	NULL
,	NULL
N.	NULL
Chirmule	NULL
,	NULL
Y.	NULL
Ohnishi	NULL
,	NULL
V.	NULL
S.	NULL
Kalyanaraman	NULL
,	NULL
and	NULL
S.	NULL
Pahwa	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
envelope	NULL
glycoproteins	NULL
gp120	NULL
and	NULL
gp160	NULL
induce	NULL
interleukin-6	NULL
production	NULL
in	NULL
CD4*	NULL
T-cell	NULL
clones	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:6277-6282	NULL
.	NULL

Oyaizu	NULL
,	NULL
N.	NULL
,	NULL
T.	NULL
W.	NULL
McCloskey	NULL
,	NULL
S.	NULL
Than	NULL
,	NULL
R.	NULL
Hu	NULL
,	NULL
V.	NULL
S.	NULL
Kalyanaraman	NULL
,	NULL
and	NULL
S.	NULL
Pahwa	NULL
.	NULL

1994	NULL
.	NULL

Cross-linking	NULL
of	NULL
CD4	NULL
molecules	NULL
upregulates	NULL
Fas	NULL
antigen	NULL
expression	NULL
in	NULL
lymphocytes	NULL
by	NULL
inducing	NULL
interferon-y	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
Â«	NULL
secretion	NULL
.	NULL

Blood	NULL
84:2622-2631	NULL
.	NULL

Platt	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
N.	NULL
Madani	NULL
,	NULL
S.	NULL
L.	NULL
Kozak	NULL
,	NULL
and	NULL
D.	NULL
Kabat	NULL
.	NULL

1997	NULL
.	NULL

Infectious	NULL
prop	NULL
HIV-1	NULL
SIGNALING	NULL
IN	NULL
INFLAMMATORY	NULL
GENE	NULL
EXPRESSION	NULL
45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

6413	NULL
erties	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
mutants	NULL
with	NULL
distinct	NULL
affinities	NULL
for	NULL
the	NULL
CD4	NULL
receptor	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:883-890	NULL
.	NULL

Popik	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Pitha	NULL
.	NULL

1991	NULL
.	NULL

Inhibition	NULL
by	NULL
interferon	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
l-activated	NULL
transcription	NULL
of	NULL
fet-defective	NULL
provirus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:9573-9577	NULL
.	NULL

Popik	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Pitha	NULL
.	NULL

1993	NULL
.	NULL

Role	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
in	NULL
activation	NULL
and	NULL
replication	NULL
of	NULL
the	NULL
tet-defective	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:1094-1099	NULL
.	NULL

Popik	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Pitha	NULL
.	NULL

1996	NULL
.	NULL

Binding	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
to	NULL
CD4	NULL
induces	NULL
association	NULL
of	NULL
Lok	NULL
and	NULL
Raf-1	NULL
and	NULL
activates	NULL
Raf-1	NULL
by	NULL
a	NULL
Ras-independent	NULL
pathway	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:6532-6541	NULL
.	NULL

Rautonen	NULL
,	NULL
N.	NULL
,	NULL
J.	NULL
Rautonen	NULL
,	NULL
N.	NULL
L.	NULL
Martin	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Wara	NULL
.	NULL

1994	NULL
.	NULL

HIV-1	NULL
Tat	NULL
induces	NULL
cytokine	NULL
synthesis	NULL
by	NULL
uninfected	NULL
mononuclear	NULL
cells	NULL
.	NULL

AIDS	NULL
8:1504-1506	NULL
.	NULL

Rosenberg	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
J.	NULL
M.	NULL
Billingsley	NULL
,	NULL
A.	NULL
M.	NULL
Caliendo	NULL
,	NULL
S.	NULL
L.	NULL
Boswell	NULL
,	NULL
P.	NULL
E.	NULL
Sax	NULL
,	NULL
S.	NULL
A.	NULL
Kalams	NULL
,	NULL
and	NULL
B.	NULL
D.	NULL
Walker	NULL
.	NULL

1997	NULL
.	NULL

Vigorous	NULL
HIV-1-specific	NULL
CD4+	NULL
T	NULL
cell	NULL
responses	NULL
associated	NULL
with	NULL
control	NULL
of	NULL
viremia	NULL
.	NULL

Science	NULL
278:1447-1450	NULL
.	NULL

Rudd	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
J.	NULL
M.	NULL
Trevillyan	NULL
,	NULL
J.	NULL
D.	NULL
Dasgupta	NULL
,	NULL
L.	NULL
L.	NULL
Wong	NULL
,	NULL
and	NULL
S.	NULL
F.	NULL
Schlossman	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
CD4	NULL
receptor	NULL
is	NULL
complexed	NULL
in	NULL
detergent	NULL
lysates	NULL
to	NULL
a	NULL
protein-tyrosine	NULL
kinase	NULL
(	NULL
pp38	NULL
)	NULL
from	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:5190-5194	NULL
.	NULL

Ruocco	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
X.	NULL
Chen	NULL
,	NULL
C.	NULL
Ambrosino	NULL
,	NULL
E.	NULL
Dragonetti	NULL
,	NULL
W.	NULL
Liu	NULL
,	NULL
M.	NULL
Mallardo	NULL
,	NULL
G.	NULL
De	NULL
Falco	NULL
,	NULL
C.	NULL
Palmieri	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
I.	NULL
Quinto	NULL
,	NULL
S.	NULL
Venuta	NULL
,	NULL
and	NULL
G.	NULL
Scala	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeats	NULL
by	NULL
interaction	NULL
of	NULL
C/EBP	NULL
(	NULL
NF-IL6	NULL
)	NULL
and	NULL
NF-kappa	NULL
B/Re	NULL
!	NULL

l	NULL
transcription	NULL
factors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
:	NULL
22479-22486	NULL
.	NULL

Schmidtmayerova	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
S.	NULL
Nottet	NULL
,	NULL
G.	NULL
Nuovo	NULL
,	NULL
T.	NULL
Raabe	NULL
,	NULL
C.	NULL
R.	NULL
Flanagan	NULL
,	NULL
L.	NULL
Dubrovsky	NULL
,	NULL
H.	NULL
E.	NULL
Gendelman	NULL
,	NULL
A.	NULL
Cerami	NULL
,	NULL
M.	NULL
Bukrinsky	NULL
,	NULL
and	NULL
B.	NULL
Sherry	NULL
.	NULL

1996	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
alters	NULL
chemokine	NULL
beta	NULL
peptide	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
:	NULL
implications	NULL
for	NULL
recruitment	NULL
of	NULL
leukocytes	NULL
into	NULL
brain	NULL
and	NULL
lymph	NULL
nodes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:700-704	NULL
.	NULL

Schols	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
E.	NULL
De	NULL
Clereq	NULL
.	NULL

1996	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
gp120	NULL
induces	NULL
anergy	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
by	NULL
inducing	NULL
interleukin-10	NULL
production	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:4953-4960	NULL
.	NULL

Strizki	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
J.	NULL
D.	NULL
Turner	NULL
,	NULL
R.	NULL
G.	NULL
Collman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Hoxie	NULL
,	NULL
and	NULL
F.	NULL
Gonzalez-Scarano	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
monoclonal	NULL
antibody	NULL
(	NULL
12G5	NULL
)	NULL
directed	NULL
against	NULL
CXCR-4	NULL
inhibits	NULL
infection	NULL
with	NULL
the	NULL
dual-tropic	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
isolate	NULL
HIV-1	NULL
(	NULL
89.6	NULL
)	NULL
but	NULL
not	NULL
the	NULL
T-tropic	NULL
isolate	NULL
HIV-1	NULL
(	NULL
HxB	NULL
)	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:5678-5683	NULL
.	NULL

Su	NULL
,	NULL
Y.	NULL
,	NULL
W.	NULL
Popik	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Pitha	NULL
.	NULL

1995	NULL
.	NULL

Inhibition	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
replication	NULL
by	NULL
a	NULL
Tat-activated	NULL
,	NULL
transduced	NULL
interferon	NULL
gene	NULL
:	NULL
targeted	NULL
expression	NULL
to	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1-infected	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:110-121	NULL
.	NULL

Tamma	NULL
,	NULL
S.	NULL
M.	NULL
L.	NULL
,	NULL
N.	NULL
Chirmule	NULL
,	NULL
H.	NULL
Yagura	NULL
,	NULL
N.	NULL
Oyaizu	NULL
,	NULL
V.	NULL
Kalyanaraman	NULL
,	NULL
and	NULL
S.	NULL
Pahwa	NULL
.	NULL

1997	NULL
.	NULL

CD4	NULL
cross-linking	NULL
(	NULL
CD4XL	NULL
)	NULL
induces	NULL
Ras	NULL
activation	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
Â«	NULL
secretion	NULL
in	NULL
CD4+	NULL
T	NULL
cells	NULL
.	NULL

Blood	NULL
90:1588-1593	NULL
.	NULL

Theodore	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
G.	NULL
Englund	NULL
,	NULL
A.	NULL
Buckler-White	NULL
,	NULL
C.	NULL
E.	NULL
Buckler	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
K.	NULL
W.	NULL
C.	NULL
Peden	NULL
.	NULL

1996	NULL
.	NULL

Construction	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
stable	NULL
full-length	NULL
macrophage-tropic	NULL
HIV	NULL
type	NULL
1	NULL
molecular	NULL
clone	NULL
that	NULL
directs	NULL
the	NULL
production	NULL
of	NULL
high	NULL
titers	NULL
of	NULL
progeny	NULL
virions	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
12:191-194	NULL
.	NULL

Veillette	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
A.	NULL
Bookman	NULL
,	NULL
E.	NULL
M.	NULL
Horak	NULL
,	NULL
L.	NULL
E.	NULL
Samelson	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Bolen	NULL
.	NULL

1989	NULL
.	NULL

Signal	NULL
transduction	NULL
through	NULL
the	NULL
CD4	NULL
receptor	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
internal	NULL
membrane	NULL
tyrosine-protein	NULL
kinase	NULL
pS6lck	NULL
.	NULL

Nature	NULL
338:257-259	NULL
.	NULL

Weissman	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
L.	NULL
Rabin	NULL
,	NULL
J.	NULL
Arthos	NULL
,	NULL
A.	NULL
Rubbert	NULL
,	NULL
M.	NULL
Dybul	NULL
,	NULL
R.	NULL
Swofford	NULL
,	NULL
S.	NULL
Venkatesan	NULL
,	NULL
J.	NULL
M.	NULL
Farber	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1997	NULL
.	NULL

Macrophage-tropic	NULL
HIV	NULL
and	NULL
SIV	NULL
envelope	NULL
proteins	NULL
induce	NULL
a	NULL
signal	NULL
through	NULL
the	NULL
CCR5	NULL
chemokine	NULL
receptor	NULL
.	NULL

Nature	NULL
389:981-985	NULL
.	NULL

Zhou	NULL
,	NULL
L.-J	NULL
.	NULL

,	NULL
and	NULL
T.	NULL
F.	NULL
Tedder	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
distinct	NULL
pattern	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
by	NULL
human	NULL
CD83+	NULL
blood	NULL
dendritic	NULL
cells	NULL
.	NULL

Blood	NULL
86:3295-3301	NULL
.	NULL

